fluorodeoxyglucose f18 has been researched along with Sarcoidosis in 528 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (1.33) | 18.2507 |
2000's | 77 (14.58) | 29.6817 |
2010's | 277 (52.46) | 24.3611 |
2020's | 167 (31.63) | 2.80 |
Authors | Studies |
---|---|
Divyateja, H; Gouni, R; Ilerhunmwuwa, NP; Thayyil, S | 1 |
Asano, M; Fuwa, M; Ikeda, T; Kanayama, T; Kato, A; Mori, I; Morita, H; Shizui, N; Taguchi, K; Tateyama, S | 1 |
Aaronson, K; Cascino, T; Koelling, T; Kopin, D; Murthy, VL; Patel, VN; Pieper, JA; Poitrasson-Rivière, A | 1 |
Freeburg, LA; Herzog, E; Miller, EJ; Moreland, H; Oatmen, KE; Shahab, Z; Spinale, FG; Young, BD | 1 |
Blankstein, R; Divakaran, S | 2 |
Blankstein, R; Castor, T; Dittmann, H; Gatidis, S; Gawaz, M; Glatthaar, A; Gräni, C; Greulich, S; Häntschel, M; Hetzel, J; Krumm, P; la Fougère, C; Mahrholdt, H; Mezger, K; Müller, KAL; Nikolaou, K | 1 |
Aikawa, T; Ibe, T; Kato, S; Manabe, O; Oyama-Manabe, N | 1 |
Miller, EJ; Park, J; Young, BD | 1 |
Borges-Rosa, J; Costa, G; de Almeida, J; Ferreira, MJ; Gomes, A; Gonçalves, L; Oliveira-Santos, M; Silva, R | 1 |
Appelbaum, J; Bhan, A; Bogun, FM; Chicos, AB; Crawford, TC; Dickfeld, T; Eagle, KA; Ellenbogen, KA; Froehlich, J; Hoogendoorn, JC; Kapa, S; Kim, HM; Kron, J; Mankad, P; Marchlinski, FE; Murgatroyd, F; Muser, D; Narasimhan, C; Patton, KK; Robinson, MR; Rosenthal, DG; Roukoz, H; Sacher, F; Santangeli, P; Sauer, WH; Siontis, KC; Soejima, K; Vedantham, V; Zeppenfeld, K; Zipse, MM | 1 |
Ovadia, M | 1 |
Ichimaru, K; Matsuura, A; Nakata, J; Nakatsuka, SI; Shibano, M; Yasuhara, Y | 1 |
Broos, WAM; Knol, RJJ; Tol, SJM; van der Zant, FM; Wondergem, M | 1 |
Artiko, VM; Milojevic, B; Milojevic, IG; Sobic-Saranovic, D | 1 |
Andreoli, C; Biscottini, E; Crusco, F; Fortuni, F; Helou, J; Marchetti, F; Quintavalle, E; Savarese, G; Scarpignato, M; Tutarini, C | 1 |
Fujii, S; Fukuda, M; Ishiguchi, H; Kawano, R; Kobayashi, S; Nakashima, Y; Nanno, T; Okamura, T; Suga, K; Yano, M; Yano, Y; Yoshiga, Y; Yoshitomi, R | 1 |
Lu, Y | 2 |
Ananthasubramaniam, K; Mshelbwala, FS | 1 |
Fujisawa, M; Kanda, T; Koga, M; Oishi, M; Sato, R; Takeshita, Y | 1 |
Bois, JP; Chareonthaitawee, P; Elwazir, MY | 1 |
Aitken, M; Balter, M; Chan, MV; Farrell, A; Hanneman, K; Islam, N; Iwanochko, M; McInnes, MDF; Metser, U; Moayedi, Y; Thavendiranathan, P; Urzua Fresno, C; Veit-Haibach, P | 1 |
Daimaru, Y; Kajitani, K; Kawamura, S; Koi, Y; Kondo, T; Ohara, M; Oride, Y; Sasada, T | 1 |
Chen, X; Su, T; Wang, R | 1 |
Bravo, PE; Han, Y; Litt, H; O'Quinn, RP; Sanghavi, M; Vidula, MK | 1 |
Fan, B; Huang, Z; Liao, F; Luo, Z; Qi, W; Xu, R; Yu, J | 1 |
Ieda, M; Ishizu, T; Kawamatsu, N; Machino-Ohtsuka, T; Sato, K; Yamamoto, M | 1 |
Pacella, S | 1 |
Higashi, H; Inoue, T; Kawaguchi, N; Kido, T; Matsuoka, M; Miyagawa, M; Miyoshi, T; Okada, T; Okayama, H; Tanabe, Y; Tashiro, R; Yamaguchi, O | 1 |
Lan, X; Shao, F; Song, X | 1 |
Aldahham, H; Gupta, R; Vender, RJ | 1 |
Aguilar-Gallardo, JS; Arreaza, J; Contreras, JP; Lasam, G; Omar, A | 1 |
Dong, J; Du, X; Li, Q; Li, S; Liu, T; Lv, Q; Ma, C; Wang, H; Xiong, R; Yang, X | 1 |
Greulich, S; Krumm, P; la Fougère, C; Nikolaou, K | 1 |
Kupari, M; Lehtonen, J; Niemelä, M; Pöyhönen, P; Schildt, J; Uusitalo, V | 1 |
Gilotra, NA; Sheikh, FH | 1 |
Hoegemann Savellano, D; Siegel, A | 1 |
Kaneko, K; Nagao, M; Sakai, A; Sakai, S; Yamamoto, A | 2 |
Basso, C; Busnardo, E; Campochiaro, C; Dagna, L; De Gaspari, M; De Luca, G; Della Bella, P; Esposito, A; Ferro, P; Gianolli, L; Palmisano, A; Peretto, G; Rizzo, S; Sala, S; Sartorelli, S; Vignale, D | 1 |
Campisi, R; Merani, MF; Rodríguez, MI | 1 |
Adams, SL; Bhattaru, A; Bravo, PE; Clancy, CB; Dubroff, J; Goldberg, L; Jean, C; Marchlinski, FE; Patel, V; Patterson, K; Peyster, E; Rojulpote, C; Rossman, M; Selvaraj, S; Vidula, MK | 1 |
Adhaduk, M; Ashwath, M; Khalid, MU; Liu, K; Mansour, S; Paudel, B | 1 |
Aikawa, T; Ibe, T; Manabe, O; Oyama-Manabe, N | 1 |
Al-Hakim, T; An, A; Buchanan, M; Heise, R; Martinez, J; Nicholson, S; Osborne, JR; Singh, P; Subramanian, K; Van Parys, J; Youn, T | 1 |
Brugger, M; Gaa, J; Scheidhauer, K | 1 |
Abe, T; Bekki, M; Fukumoto, Y; Fukuoka, R; Honda, A; Igata, S; Maeda-Ogata, S; Sugiyama, Y; Tahara, A; Tahara, N | 1 |
Alpendurada, F; Azzu, A; Baksi, J; Gardezi, SKM; Hatipoglu, S; Izgi, C; Khattar, R; Kouranos, V; Mohiaddin, R; Pennell, DJ; Sharma, R; Wechalekar, K; Wells, AU | 1 |
Park, JB; Sohn, DW | 1 |
Akdim, F; Grutters, JC; Keijsers, RGM; Mathijssen, H; Post, MC; van de Garde, EMW; Veltkamp, M; Vis, R | 1 |
Arment, CA; Bois, JP; Chareonthaitawee, P; Cooper, LT; Elwazir, MY; Ezzeddine, OFA; Kolluri, N; Rosenbaum, AN; Sykora, D; Young, KA | 1 |
Aitken, M; Balter, M; Broncano, J; Chan, MV; Davidson, M; Farrell, A; Hanneman, K; Huo, YR; Iwanochko, MR; McAllister, BJ; McInnes, MDF; Moayedi, Y; Thavendiranathan, P; Urzua Fresno, C; Vasquez, LI | 1 |
Barkmeier, D; Davenport, MS; Frey, KA; Saleh, JK | 1 |
Fukushima, A; Kawai, H; Sarai, M; Tanahashi, S; Toyama, H; Tsujimoto, M; Watanabe, M | 1 |
Benali, K; Régis, C; Rouzet, F | 1 |
Hanaoka, K; Ishii, K; Iwanaga, Y; Kaida, H; Morimoto-Ishikawa, D; Nakazawa, G; Watanabe, S; Yamada, T; Yasuda, M | 1 |
Fujiki, S; Inomata, T; Ishihara, S; Ishizuka, M; Kase, M; Kashimura, T; Okubo, T; Ozaki, K; Sakai, R; Takayama, T; Watanabe, M | 1 |
Divakaran, S | 1 |
Alshaheen, M; Beanlands, R; Birnie, D; Boczar, KE; Caires, MC; Chow, BJ; deKemp, R; Lauzier, PT; Wiefels, C | 1 |
Griffin, JM | 1 |
Iso-Mustajärvi, S; Sillanmäki, S | 1 |
Cadrin-Tourigny, J; Harel, F; Lucinian, YA; Martineau, P; Pelletier-Galarneau, M; Poenaru, R; Tremblay-Gravel, M | 1 |
Francesqui, J; Marrades, P; Sellares, J | 1 |
Aikawa, T; Fujita, H; Ibe, T; Kawakami, H; Maki, H; Manabe, O; Ohtsuka, A; Oyama-Manabe, N; Takahashi, K | 1 |
Divakaran, S; John, LA; Tedrow, UB | 1 |
Birnie, DH; Culver, DA; De Bortoli, A; Kron, J; Lehtonen, J; Murgatroyd, F; Nagai, T; Nery, PB | 1 |
Bhambhvani, P; Farag, AA; Hage, FG; Kherajani, P; Morgan, WS | 1 |
Arment, C; Bois, J; Castrichini, M; Churchill, R; Elwazir, M; Myasoedova, E; Rosenbaum, A; Sykora, D; Young, K | 1 |
Brinth, LS; Danebod, K; Dreyer, M; Klarskov, CK | 1 |
Algodayan, S; Bomanji, J; Fraioli, F; Priftakis, D | 1 |
Jabbar, PK; Karthik, V; Nair, A; Roshan, R | 1 |
Azimi, AR; Doosti, R; Dousti, S; Heidari, H; Kohandel, K; Rabiei, P; Shahmohammdi, A; Shahmohammdi, S; Shajari, Z | 1 |
Beanlands, R; Birnie, D; de Kemp, R; Juneau, D; Leung, E; Martineau, P; Nery, PB; Pelletier-Galarneau, M | 1 |
Baumwol, J; Dembo, L; Dwivedi, G; Giudicatti, L; Marangou, J; Nolan, D | 1 |
Benn, BS; De Marco, T; Gerstenfeld, EP; Hsia, HH; Janmohamed, M; Klein, L; Koth, LL; Lee, BK; Moss, JD; Murray, TO; Pampaloni, MH; Parwani, P; Petek, BJ; Rosenthal, DG; Scheinman, MM; Selby, V; Vedantham, V; Zikherman, J | 1 |
Cayci, Z; Dincer, E; Linden, MA; Omer, AK; Ozturk, K; Peterson, BA; Sachs, Z; Ustun, C | 1 |
Aarntzen, EHJG; Gerritsen, WR; van Willigen, WW | 1 |
Aikawa, T; Anzai, T; Furuya, S; Koyanagawa, K; Kuzume, M; Manabe, O; Naya, M; Ohira, H; Oyama-Manabe, N; Tsujino, I | 1 |
Amaral, S; Carvalho, J; Costa, M; Davies, M; Domingues, I; Eufrásio, J; Garcia, R; Khouri, L; Pinheiro, S; Pires, I; Pratas, E; Teixeira, M | 1 |
Fujii, S; Ishiguchi, H; Kajii, T; Kobayashi, S; Kohno, M; Nanno, T; Okada, M; Okuda, S; Suga, K; Yano, M; Yoshitomi, R | 1 |
Gule-Monroe, MK; Johnson, JM; Ordóñez-Rubiano, EG; Row, W; Solano-Noguera, DF; Tatsui, CE; Weinberg, J | 1 |
Birnie, D; Kron, J; Mankad, P; Mitchell, B | 1 |
Nagai, T; Nagoshi, T; Tanaka, TD; Yoshimura, M | 1 |
Benetos, G; Giannopoulos, AA | 1 |
De Vos, N; Devos, D; Goethals, I; Van Schandevyl, S; Waterschoot, R | 1 |
Aikawa, T; Anzai, T; Furuya, S; Hirata, K; Koyanagawa, K; Kudo, K; Kuge, Y; Magota, K; Manabe, O; Naya, M; Ohira, H; Oyama-Manabe, N; Shiga, T; Tamaki, N; Tsujino, I | 1 |
Aikawa, T; Anzai, T; Furuya, S; Hirata, K; Koyanagawa, K; Manabe, O; Naya, M; Ohira, H; Otaki, Y; Oyama-Manabe, N; Tamaki, N; Tomiyama, Y; Tsujino, I | 1 |
Chen, EH; Chrispin, J; Gilotra, NA; Griffin, JM; Kasper, EK; Okada, DR; Saad, E; Solnes, LB; Tandri, H; Wand, AL | 1 |
Tana, C | 1 |
Maccarone, MT | 1 |
Bianco, F; Bucciarelli, V; Caulo, M; Donato Aquaro, G; Gallina, S; Grigoratos, C; Mantini, C; Mastrodicasa, D; Raffaele Cotroneo, A; Ricci, F; Tana, C | 1 |
Artiko, VM; Beatovic, S; Milojevic, IG; Petrovic, N; Sobic-Saranovic, D; Tadic, M | 1 |
Altini, C; Cimino, A; Fanelli, M; Ferrari, C; Niccoli Asabella, A; Rubini, G | 1 |
Kluger, N | 1 |
Lepiorz, M; Pfeifer, M | 1 |
Schwartz, RG; Vidula, H | 1 |
Awaya, T; Hiroe, M; Hiroi, Y; Hotta, M; Kaneko, H; Minamimoto, R; Nakajima, K; Okazaki, O; Yamashita, H | 1 |
Gecelter, R; Nichols, K; Van Tosh, A | 1 |
AlBassam, O; Bowers, N; Iwanochko, R; Redwood, T | 1 |
Basu, S; Kalshetty, A | 1 |
Ambrosini, V; Fanti, S; Mei, R; Nava, S; Prediletto, I | 1 |
Fujinaga, Y; Fujita, A; Hamano, H; Hanaoka, M; Kawa, S; Kawakami, S; Komatsu, M; Oguchi, K; Ozawa, Y; Uehara, T; Ushiki, A; Yamamoto, H; Yasuo, M | 1 |
Akiyama, K; Ando, T; Azuma, A; Fukushima, Y; Iwasaki, YK; Kumita, SI; Seino, Y; Shimizu, W; Yodogawa, K | 1 |
Emdin, M; Genovesi, D; Giorgetti, A | 1 |
Booij, J; Brouwer, MC; Fritz, D; van de Beek, D | 1 |
Apollonatou, V; Chatziioannou, S; Georgakopoulos, A; Kallergi, M; Kallieri, M; Kelekis, NL; Kolilekas, L; Malagari, K; Manali, ED; Papadaki, G; Papaioannou, AI; Papaporfyriou, A; Papiris, SA; Pianou, NK; Pneumatikos, SG | 1 |
Berman, DS; Cadet, S; Friedman, J; Hamilton, MA; Hayes, S; Kransdorf, E; Miller, RJH; Patel, J; Pope, A; Pournazari, P; Slomka, PJ; Tamarappoo, B; Thomson, L | 1 |
Kobayashi, M | 1 |
Brice, AE; Hanna, C; Ostwani, W; Wymer, DC | 1 |
Chen, G; Chen, X; Fu, Z; Li, Q | 1 |
Fujimoto, K; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Yamamoto, Y | 1 |
Fujita, S; Fujiyoshi, H; Hoshiga, M; Inoue, M; Kanzaki, Y; Miyamura, M; Morimoto, T; Terasaki, F | 1 |
Kumar, A; Mitra, S; Muthu, GS; Parida, GK; Suman, A | 1 |
Hagiwara, K; Hayashida, M; Nagamoto, S; Ogawa, K; Okaneya, T; Sakaguchi, K; Sawa, N; Urakami, S; Yano, A | 1 |
Ishii, J; Kato, Y; Kawai, H; Matsuyama, T; Morimoto, SI; Motoyama, S; Naruse, H; Ozaki, Y; Sarai, M; Takahashi, H; Toyama, H; Watanabe, A | 1 |
El Ghannudi, S; Imperiale, A; Martinez, M; Ohlmann, P; Poindron, V; Schindler, TH | 1 |
Brunken, RC | 1 |
Dedeoglu, SE; Kubat, B; Sayman, H; Tetikkurt, C; Tetikkurt, S | 1 |
Iida, S; Matsuda, N; Ogino, Y; Saito, N; Yasutake, M | 1 |
Chotipanich, C; Kunawudhi, A; Promteangtrong, C; Vachatimanont, S | 1 |
Jeeva, G; Santhosh, S; Thirumalairaj, R | 1 |
Alqarawi, W; Beanlands, R; Birnie, D; Celiker-Guler, E; Chakrabarti, S; de Kemp, R; Healey, JS; Hruczkowski, TW; Juneau, D; Leung, E; Medor, MC; Nery, PB; Odabashian, R; Promislow, S; Quinn, FR; Spence, S; Weng, W; Wiefels, C | 1 |
Dhanapalaratnam, R; Huynh, W | 1 |
Birnie, DH | 1 |
Ahmed, S; Chen, ES; Constantinescu, F; Devraj, M; Garcia, C; Gilotra, NA; Griffin, JM; Kasper, EK; Mohammed, SF; Okada, DR; Pavlovic, N; Pillarisetty, A; Saad, E; Sheikh, FH; Solnes, L; Wand, AL | 1 |
Dempsey, OJ; Hu, MK; Mathur, A | 1 |
Berger, RD; Calkins, H; Chrispin, J; Derakhshan, A; Gilotra, NA; Gowani, Z; Habibi, M; Misra, S; Okada, DR; Smith, J; Tandri, H; Zimmerman, SL | 1 |
Kamiya, T; Murakami, S; Naka, S; Shimamoto, H; Watabe, T | 1 |
Hanaoka, K; Ishii, K; Iwanaga, Y; Kagioka, Y; Kaida, H; Kakehi, K; Kawamura, T; Miyazaki, S; Nakazawa, G; Okune, M; Soejima, N; Yasuda, M | 1 |
Cuspidi, C; Milojevic, B; Milojevic, IG; Saeed, S; Tadic, M | 1 |
Cremer, PC; Hutt, E; Jaber, WA; Jellis, C; Mountis, MM | 1 |
Dziuk, M; Marciniak-Emmons, M; Osiecki, S; Sterliński, M | 1 |
Barber, TW; Beech, PA; Cherk, MH; Hare, JL; Khor, R; Kyprianou, K; Larby, A; Nadebaum, DP; Sankaran, SS; Yap, KS; Zimmet, H | 1 |
Cuocolo, A; Imbriaco, M; Nappi, C; Ponsiglione, A | 1 |
Dodd, JD; Keane, D; Keane, MP; Kelly, A; McCarthy, C; Murphy, DJ | 1 |
Appelbaum, DE; Carter, SV; Flatley, E; Kebed, KY; Lang, RM; Moss, JD; Patel, AR; Singh, A; Tung, R; Ward, RP | 1 |
Kuzume, A; Matsue, K; Miura, D; Takeuchi, K; Terao, T | 1 |
Bilgic, S; Bilgin, S; Bilir, M; Kubat, B; Sayman, BH; Tetikkurt, C; Tetikkurt, S; Yanardag, H | 1 |
Mohyuddin, T; Moloney, M; O'Riordan, K | 1 |
Ali, AZ; Kishore, J; Narasimhan, C; Saggu, DK; Subramanian, M; Swamy, LTN; Swapna, N; Yalagudri, S | 1 |
Haq, A; Jain, S; Schindler, TH | 1 |
Akdim, F; Azzahhafi, J; Bakker, ALM; Grutters, JC; Keijsers, RGM; Mathijssen, H; Post, MC; Swaans, MJ; Veltkamp, M | 1 |
Avery, R; Cao, J; Cooper, LT; Lomasney, JW; Narang, A; Okwuosa, IS; Passman, RS; Schwartz, YY; Vorovich, E | 1 |
Ando, K; Fukushima, K; Hagiwara, N; Imamura, Y; Momose, M; Nagao, M; Nakao, R; Sakai, A; Sakai, S; Suzuki, A; Watanabe, E; Yamamoto, A | 1 |
Bois, JP; Chareonthaitawee, P | 1 |
Cornelis, L; De Meester, L; De Scheerder, MA; Van Dorpe, J | 1 |
Arnfield, E; Pattison, DA | 1 |
Aloè, T; Barisione, E; Bauckneht, M; Cittadini, G; Guadagno, A; Morbelli, S; Tagliabue, E | 1 |
Lu, Y; Macapinlac, HA; Sweiss, NJ | 2 |
Nishiyama, Y; Norikane, T | 1 |
Agrawal, T; Al-Mallah, M; Alnabelsi, TS; Bhimaraj, A; Kassi, M; Khan, M; Saleh, Y; Sukkari, MH | 1 |
Beuzit, S; de Moreuil, C; Gobert, M; Rouvière, B | 1 |
Abe, T; Bekki, M; Enomoto, M; Fukumoto, Y; Honda, A; Igata, S; Kaida, H; Kakuma, T; Maeda-Ogata, S; Sugiyama, Y; Tahara, A; Tahara, N | 1 |
Abebe, AT; Agrawal, T; Ahmed, AI; Al-Mallah, MH; Aljizeeri, A; Alnabelsi, T; Han, Y; Kassi, M; Taylor, A; Tleyjeh, IM | 1 |
Chiovaro, JC; Desai, AK | 1 |
Fayad, ZA; Hirata, N; Jacobi, A; Kovacic, JC; Lescure, T; Liao, SL; Maier, A; Morgenthau, A; Narula, J; Narula, N; Padilla, M; Robson, PM; Sartori, S; Soultanidis, G; Trivieri, MG; Vergani, V | 1 |
Abdelshafee, M; Abouezzeddine, OF; Amin, S; Bois, JP; Chareonthaitawee, P; Christopoulos, G; Cooper, JLT; Elwazir, M; Jouni, H; Kendi, AT; Krause, ML | 1 |
Andrikopoulou, E; Bajaj, N; Bhambhvani, P; Manapragada, PP | 1 |
Brunken, R; Culver, D; Ibrahim, A; Marwick, TH; Negishi, K; Negishi, T; Patel, P; Popović, ZB; Sperry, BW; Tamarappoo, B | 1 |
Guo, HH; Hanneman, K; Herfkens, R; Iagaru, A; Jamali, M; Kadoch, M; Quon, A | 1 |
Okada, M; Rokutanda, R; Tomishima, Y | 1 |
Mihara, Y; Okabe, Y; Torimura, T; Ushijima, T; Yasunaga, M | 1 |
Baratto, L; Davidzon, G; Gambhir, SS; Hatami, N; Iagaru, A; Park, SY; Srinivas, S | 1 |
Haarala, A; Kähönen, M; Korkola, P; Nikus, K; Sipilä, K; Tikkakoski, A; Tuominen, H | 1 |
Abgral, R; Chang, HL; Contreras, J; Dweck, MR; Fayad, ZA; Fuster, V; Karakatsanis, N; Kovacic, JC; Lala, A; Mani, V; Miller, MA; Narula, J; Padilla, M; Palmisano, A; Robson, PM; Sanz, J; Trivieri, MG | 1 |
Schindler, TH | 1 |
Lu, Y; Sanan, P | 1 |
Kouranos, V; Wechalekar, K | 1 |
Lu, Y; Patel, DC; Sweiss, N | 1 |
Goettl, C; Gunasekaran, SS; Lu, Y; Patel, DC; Sweiss, NJ | 1 |
Belperio, JA; Bradfield, JS; Lynch, JP; Moriarty, JM; Sayah, DM | 1 |
Beanlands, RS; Birnie, DH; Blankstein, R; Borges-Neto, S; Chareonthaitawee, P; Chen, ES; Chen, W; Cooper, LT; Di Carli, MF; Dorbala, S; Gropler, RJ; Miller, EJ; Murthy, VL; Ruddy, TD; Schindler, TH; Tung, RH; White, ES | 2 |
Kai, K; Kimura, S; Kojima, K; Kusaba, K; Naito, S; Nishida, Y; Taba, M; Ureshino, H | 1 |
Bhambhvani, P; Valentin, RC | 1 |
Agarwal, V; Blankstein, R | 1 |
Brunken, R; Cerqueira, MD; Culver, DA; Hachamovitch, R; Javed, O; Oldan, JD; Sperry, BW; Tamarappoo, BK | 1 |
Kiko, T; Masuda, A; Nemoto, A; Oriuchi, N; Takeishi, Y; Tominaga, H; Yoshihisa, A | 1 |
Ahonen, AA; Hippeläinen, ET; Loimaala, AJ; Schildt, JV | 1 |
Furukawa, D; Kawahara, T; Ohtani, K; Tsutsui, H; Yakabe, D | 1 |
Ahmed, J; Feiglin, D; Liu, K | 1 |
Blankstein, R; Donal, E; Dorbala, S; Gheysens, O; Gimelli, A; Glaudemans, AWJM; Hacker, M; Hyafil, F; Jaber, WA; Lancellotti, P; Miller, EJ; Plein, S; Rouzet, F; Russell, R; Schwartz, RG; Slart, RHJA | 1 |
O'Gara, PT; Stewart, GC; Wadhera, RK | 1 |
Beanlands, R; Birnie, D; Ohira, H | 1 |
Chu, G; Chung, T; Hunyor, I; Kane, A; Limaye, S; Murad, A; Riminton, S; Russo, R; Sasson, SC; Williamson, J | 1 |
Haarala, A; Kähönen, M; Nikus, K; Sipilä, K; Tikkakoski, A; Tuominen, H | 3 |
Bremer, W; Lu, Y; Sweiss, NJ | 1 |
Connolly, M; Crowther, S; Feeney, J; Gillis, A; Kelleher, F; McKenna, MC; Molloy, K | 1 |
Beanlands, RSB; Birnie, DH; de Kemp, RA; Juneau, D; Leung, E; Nery, P; Russo, J | 1 |
Schindler, TH; Valenta, I | 1 |
Barnes, A; Booth, HL; Elliott, PM; Garrett, E; Groves, AM; Menezes, LJ; Mohiddin, SA; Patel, RS; Pavlou, M; Porter, JC; Sekhri, N; Wicks, EC | 1 |
Higuchi, Y; Horiuchi, T; Kimoto, Y; Maeda, T; Tanoue, R; Tokunou, T; Tomonari, K | 1 |
Agrawal, M; Blankstein, R; Bravo, PE; Di Carli, MF; Dorbala, S; Hulten, E; Kwong, RY; Madan, R; Mullins, E; Okada, DR; Skali, H; Steigner, M; Stewart, GC; Taqueti, VR; Veillet-Chowdhury, M; Vita, T | 1 |
Culver, DA; Miller, EJ | 1 |
Bhambhvani, P; Hage, FG; Iskandrian, AE; Saab, R | 1 |
Awaya, T; Hiroi, Y; Hotta, M; Kubota, S; Minamimoto, R | 1 |
Grosse, J; Hellwig, D; Menhart, K; Schmidbauer, B | 1 |
Aiki, T; Hasegawa, K; Kaseno, K; Tada, H | 1 |
Alavi, A; Callans, DJ; Castro, SA; Desjardins, B; Dixit, S; Enriquez, A; Garcia, FC; Hayashi, T; Liang, JJ; Magnani, S; Marchlinski, FE; Muser, D; Nucifora, G; Santangeli, P; Werner, TJ; Zado, ES | 1 |
Fujita, SI; Hirose, Y; Ishizaka, N; Kanzaki, Y; Terasaki, F | 1 |
Banzo, I; González-Gay, MA; Jiménez-Bonilla, JF | 1 |
Atterton-Evans, V; Robertson, T; Turner, J; Vivanti, A | 1 |
De Rosa, S; Indolfi, C; Iwanaga, Y; Kawamura, T; Miyazaki, S; Nakamura, T; Yasuda, M | 1 |
Bekki, M; Fukumoto, Y; Sugiyama, Y; Tahara, A; Tahara, N | 1 |
Malhotra, S; Schwartz, RG | 1 |
Wechalekar, K | 1 |
Aikawa, T; Hayashi, S; Hirata, K; Koyanagawa, K; Magota, K; Manabe, O; Naya, M; Ohira, H; Oyama-Manabe, N; Tamaki, N; Tomiyama, Y; Tsujino, I; Yoshinaga, K | 1 |
Blankstein, R; Bravo, PE; Di Carli, MF; Singh, A | 1 |
Bokhari, S; Flaherty, KR; Flores, RJ; Jin, Z | 1 |
Bouvry, D; Brillet, PY; Djelbani, S; Meune, C; Nunes, H; Sgard, B; Soussan, M; Valeyre, D | 1 |
Better, N; Montalto, S | 1 |
Kim, K; Kim, SJ; Pak, K | 1 |
Aikawa, T; Anzai, T; Kamiya, K; Kato, Y; Komoriyama, H; Koyanagawa, K; Kuzume, M; Manabe, O; Nagai, T; Naya, M; Omote, K; Tamaki, N | 1 |
Hachamovitch, R; Sperry, BW | 1 |
Lai, JKC; Lichtenstein, M; Sivaratnam, D; Teo, E; Toh, HB | 1 |
Buck, AK; Dierks, A; Kircher, M; Kramer, D; Lapa, C; Schmid, SJ | 1 |
Abdelmessih, M; Baldassarre, LA; Miller, EJ; Rosenfeld, LE; Sharp, MB; Soufer, A | 1 |
Hyafil, F; Le Guludec, D; Rouzet, F | 1 |
Chareonthaitawee, P; Jouni, H | 1 |
Aikawa, T; Anzai, T; Koyanagawa, K; Kuzume, M; Manabe, O; Naya, M; Ohira, H; Tamaki, N; Tsujino, I | 1 |
Arai-Okuda, H; Ihara, A; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Tanaka, K; Yamamoto, Y | 1 |
Fowler, M; Guo, HH; Iagaru, A; Mittra, E; Ning, N; Witteles, R | 1 |
Bois, JP; Chareonthaitawee, P; Muser, D | 1 |
Alavi, A; Castro, SA; Muser, D; Santangeli, P | 1 |
Alvi, RM; Herzog, E; Miller, EJ; Pan, H; Shahab, Z; Winkler, J; Young, BD | 1 |
Fahad, F; Saad Shaukat, MH; Torosoff, M; Weinreb, D | 1 |
Krombach, GA; Litzlbauer, D; Wörner, JM | 1 |
Aikawa, T; Anzai, T; Koyanagawa, K; Oyama-Manabe, N | 1 |
Enzan, N; Nagaoka, K; Ohtani, K; Sakamoto, I; Tsutsui, H | 1 |
Baldari, S; Laudicella, R; Minutoli, F | 1 |
Abisror, N; Bonnet, P; Fain, O; Mekinian, A; Soussan, M | 1 |
Montero de la Peña, A; Viteri Jusué, A | 1 |
Adachi, M; Ito, Y; Nagata, Y; Nakano, K; Ono, T; Sakamoto, N; Takaba, M; Takagi, F; Takemura, T; Uchiyama, S; Yoda, A | 1 |
Besson, FL; Bompard, F; Chekroun, M; de Menthon, M; Durand, E; Gomez, L; Gottlieb, J; Goujard, C; Grimon, G; Saleh, NS | 1 |
Altini, C; Bauckneht, M; Borra, A; Caobelli, F; Ferrari, C; Ferro, P; Genovesi, D; Monaco, L; Popescu, CE | 1 |
Blankstein, R; Desai, AS; Di Carli, MF; Divakaran, S; Dorbala, S; Ghoshhajra, BB; Givertz, MM; Hedgire, SS; Kwong, RY; Lakdawala, NK; Mehra, MR; Padera, RF; Skali, H; Stewart, GC; Taqueti, VR; Zhou, W | 1 |
Bajaj, N; Bibbo, CF; Blankstein, R; Bravo, PE; Di Carli, MF; Dorbala, S; Groarke, J; Hainer, J; Harrington, M; Hyun, H; Lakdawala, NK; Morgan, V; Padera, RF; Park, MA; Robertson, M; Stewart, GC | 1 |
Kasai, T; Kiso, K; Kumita, S; Miyagawa, M; Momose, M; Naya, M; Yoshinaga, K | 1 |
Greib, C; Lazaro, E; Machelart, I; Pellegrin, JL; Rivière, E; Schwartz, P; Viallard, JF | 1 |
Divakaran, S; Osborne, MT | 1 |
Fujita, S; Hoshiga, M; Inuyama, M; Kanzaki, Y; Maeda, D; Miyamura, M; Takashima, S; Terasaki, F | 1 |
Dhomps, A; Foret, T; Skanjeti, A; Streichenberger, N; Tordo, J | 1 |
Bando-Delaunay, A; Cassou-Mounat, T; Huchet, V; Jehanno, N; Luporsi, M | 1 |
Narula, J; Narula, N; Zubin Maslov, P | 1 |
Adams, HS; Agarwal, S; Ha, FJ; Palmer, SC; Thillai, M; Tweed, K; Williams, L | 1 |
Javadi, MS; Rowe, SP; Solnes, LB; Tulbah, RI | 1 |
Broadhurst, PA; Choo, WK; Dawson, DK; Dempsey, OJ; Denison, AR; Miller, DR | 1 |
Ambrosini, V; Fanti, S; Fasano, L; Nanni, C; Nava, S; Rubello, D; Zompatori, M | 1 |
Artiko, VM; Grozdic, IT; Obradovic, VB; Pavlovic, SV; Saranovic, DZ; Sobic-Saranovic, DP; Videnovic-Ivanov, J; Vucinic-Mihailovic, V | 1 |
Dorbala, S; Schulman, AR; Skali, H | 2 |
Augier, A; Brillet, PY; Soussan, M; Valeyre, D; Weinmann, P | 1 |
Braun, JJ; Imperiale, A; Riehm, S | 1 |
Buckner, JK; Curran-Everett, D; Fenster, BE; Freeman, AM; Gottschall, EB; Hamzeh, NY; Maier, LA; Sauer, WH; Weinberger, HD | 1 |
Chen, A; Khanna, P; Russell, R; Siddon, A | 1 |
Ito, K; Kubota, K; Minamimoto, R; Miyata, Y | 1 |
Agarwal, R; Akin, EA; Ionita, JA; Sadeghi, N; Taheri, MR | 1 |
Ito, YM; Klaipetch, A; Manabe, O; Nishimura, M; Ohira, H; Oyama-Manabe, N; Sato, T; Tamaki, N; Tsujino, I; Yoshinaga, K | 1 |
Butler, J; Prato, FS; Rajchl, M; Thompson, RT; White, JA; Wisenberg, G | 1 |
Ishibashi, K; Takeda, M; Yamahara, Y | 1 |
Beanlands, RS; Birnie, DH; DaSilva, J; de Kemp, RA; Klein, R; Leung, E; Mc Ardle, BA; Nery, PB; Renaud, J; Wells, GA | 1 |
Grutters, JC; Keijsers, RG; Rijkers, GT; van Moorsel, CH; Verwoerd, A; Vorselaars, AD | 1 |
Han, EJ; Jang, YS; Kang, S; Kim, HS; Lee, IS; Lee, JM | 1 |
Judson, MA; Kalkanis, AG; Kalkanis, DG; Polychronopoulos, VS | 1 |
Artiko, V; Obradovic, V; Sobic-Saranovic, D | 1 |
Li, D; Lü, PX | 1 |
Bendstrup, E; Christensen, NL; Gormsen, LC; Nielsen, SS; Tolbod, LP | 1 |
Arana Yi, C; Axelrod, R; Machtay, M; McCue, P; Morris, GJ; Rosen, M | 1 |
Blankstein, R; Di Carli, MF; Dorbala, S; Hainer, J; Kazemian, P; Kim, CK; Kwong, RY; Murthy, VL; Naya, M; Osborne, M; Padera, R; Skali, H; Stevenson, WG; Tokuda, M; Waller, A | 1 |
Bengel, FM; Schatka, I | 1 |
Altini, C; Cappabianca, S; Fanelli, M; Niccoli Asabella, A; Notaristefano, A; Rotondo, A; Rubini, G; Stabile Ianora, AA | 1 |
Egashira, T; Fujita, J; Fukuda, K; Inohara, T | 1 |
Bokhari, S; Paz, YE | 1 |
Bittencourt, MS; Blankstein, R; Di Carli, MF; Dorbala, S; Hainer, J; Hulten, EA; Murthy, VL; Osborne, MT; Singh, A; Skali, H; Stewart, GC; Waller, AH | 1 |
Botvinick, E; Hernandez Pampaloni, M; Nazar, B; Nazer, B | 1 |
Egashira, T; Fukuda, K; Kunitomi, A; Maekawa, Y; Makino, S; Okada, M | 1 |
Ishida, Y; Kiso, K; Kondoh, C; Kumita, S; Miyagawa, M; Moroi, M; Yoshinaga, K | 1 |
Hirami, Y; Maeda, A; Nakata, M; Shimizu, K; Yasuda, K; Yukawa, T | 1 |
Accardo, M; Fiorelli, A; Orditura, M; Santini, M | 1 |
Beanlands, RS; Birnie, DH; Davis, D; Gollob, MH; Green, M; Healey, JS; Leung, E; McArdle, BA; Nair, GM; Nery, PB; Ohira, H; Yang, J | 1 |
Jolepalem, P; McLean, KZ; Wong, CY | 1 |
Bratu, VA; Fischmann, A; Hostettler, KE; Studler, U; Tamm, M | 1 |
Bhattacharya, A; Gupta, D; Jung, RS; Kumar, R; Maturu, NV; Mittal, BR | 1 |
Annunziata, S; Bertagna, F; Caldarella, C; Giovanella, L; Sobic-Saranovic, D; Treglia, G | 1 |
Cremers, JP; Drent, M; Koek, GH; Mostard, RL; Van Kroonenburgh, MJ; Vöö, SA; Wijnen, PA | 1 |
Higaki, J; Miyagawa, M; Mochizuki, T; Nishiyama, Y; Ogimoto, A; Yokoyama, R | 1 |
Gaertner, FC; Manabe, O; Nakagaki, T; Nishio, S; Suzuki, A; Tamaki, N; Toyonaga, T | 1 |
Ahmadian, A; Berman, J; Brogan, A; Govender, P; Mazzini, M; Mercier, G; Miller, EJ; Ruberg, FL; Sverdlov, AL | 1 |
Magota, K; Manabe, O; Masuda, A; Nishimura, M; Ohira, H; Oyama-Manabe, N; Sato, T; Tamaki, N; Tsujino, I; Yamada, A; Yoshinaga, K | 1 |
Blankstein, R; Waller, AH | 1 |
Liu, Y | 1 |
Adams, H; Grutters, JC; Keijsers, RG; Korenromp, IH | 1 |
Bradfield, J; Fishbein, M; Hwang, J; Lynch, JP; Shivkumar, K; Tung, R | 1 |
Gerbaudo, VH; Wachsmann, JW | 1 |
Koh, AS; Kok, TY; Lath, N; Sim, DK; Tan, RS | 1 |
Hiroe, M; Ito, K; Kubota, K; Minamimoto, R; Morooka, M; Okazaki, O | 1 |
He, ZX; Jain, D; Lele, V | 1 |
Akasaka, T; Imanishi, T; Orii, M | 1 |
Doudouh, A; El Hammoumi, M; El Marjany, M; Kabiri, el H; Mansouri, H; Moussaoui, D | 1 |
Asuaje, ED; Buteau, JP; Keu, KV; Ochoa, CA; Rizcallah, E; Rousseau, É; Turcotte, É | 1 |
Czyżewski, D; Gabryś, J; Kuś, E | 1 |
David, O; Lu, Y; Zivin, S | 1 |
Liepe, K | 1 |
Ding, X; Feng, H; Han, Z; Lei, X; Liang, Y; Meng, J; Zhang, C; Zhang, Y | 1 |
Bayram, M; Erdoğan, EB; Özçelik, HK; Özkan, D; Sezer, M; Tabak, L; Yakar, A; Yakar, F | 1 |
Ashikaga, T; Hirao, K; Hirasawa, K; Isobe, M; Kato, Y; Maejima, Y; Sasaoka, T; Suzuki, J; Terashima, M; Tezuka, D; Toriihara, A; Yoshikawa, S | 1 |
Casset-Senon, D; Cosnay, P; Diot, P; Lorette, G; Philippe, L | 1 |
Nunes, H; Silva, M; Sverzellati, N; Valeyre, D | 1 |
Bos, WJ; Grutters, JC; van Moorsel, CH; van Velzen-Blad, H; Verwoerd, A; Vorselaars, AD | 1 |
Kaur, D; Lalukota, K; Narasimhan, C; Panda, S; Pavri, BB; Sundar, G | 1 |
Gonzalez, WO; Massera, D; Travin, MI | 1 |
Bonella, F; Costabel, U; Wessendorf, TE | 1 |
Di Biagio, A; Ferrarazzo, G; Fiz, F; Nicolini, LA; Sambuceti, G; Taramasso, L; Viscoli, C | 1 |
Chae, EJ; Do, KH; Hwang, HJ; Kim, EY; Kim, JE; Koo, HJ; Lee, HJ; Oh, SY | 1 |
Hsich, EM; Oldan, JD; Reynolds, JP; Sperry, BW; Tamarappoo, BK | 1 |
Higaki, J; Inoue, T; Miki, H; Miyagawa, M; Mochizuki, T; Ogimoto, A; Okayama, H; Yokoyama, R | 1 |
Basu, S; Hansson, SH; Hess, S; Høilund-Carlsen, PF; Pedersen, KT | 1 |
Aggarwal, NR; Chareonthaitawee, P; Cooper, LT; Gersh, BJ; Snipelisky, D; Young, PM | 1 |
Akasaka, T; Hirata, K; Ino, Y; Kubo, T; Matsuo, Y; Orii, M; Ota, S; Shiono, Y; Tanaka, A; Tanimoto, T; Yamaguchi, T; Yamano, T | 1 |
Choi, CM; Kim, MY; Kim, SS; Koo, HJ; Lee, SW; Shin, S; Shin, SY | 1 |
Bateman, TM; Coggins, T; Main, ML; Saeed, IM | 1 |
Hirata, K; Manabe, O; Masuda, A; Nishimura, M; Ohira, H; Oyama-Manabe, N; Sato, T; Tamaki, N; Tsujino, I; Yamada, A; Yoshinaga, K | 1 |
Nguyen, TT; Parker, BJ; Yachoui, R | 1 |
Al-Faham, Z; Jolepalem, P; Oliver Wong, CY | 1 |
Chowdhury, M; Farooqi, F; Honarbakhsh, S; Mcbeath, K | 1 |
Blankstein, R; Kinno, M; Waller, AH | 1 |
Kouranos, V; Sharma, R; Underwood, SR; Wechalekar, K; Wells, AU | 1 |
Beanlands, RSB; Bernick, J; Birnie, DH; Chow, BJW; Davies, R; deKemp, RA; Dennie, C; Dick, A; Hessian, R; Klein, R; Leung, E; Liu, P; Manabe, O; Mc Ardle, B; Nery, PB; Nishimura, M; Ohira, H; Oyama-Manabe, N; Pena, E; Renaud, J; Ruddy, TD; Sato, T; Tamaki, N; Tsujino, I; Wells, GA; Yoshinaga, K | 1 |
Chen, S; Duan, L | 1 |
Airaksinen, J; Haataja, P; Kandolin, R; Kupari, M; Lehtonen, J; Marjasuo, S; Miettinen, H; Schildt, J; Simonen, P; Tuohinen, S; Vihinen, T | 1 |
Bernaudin, JF; Boussouar, S; Brillet, PY; Kambouchner, M; Martin, A; Medjhoul, A; Nunes, H; Soussan, M; Tayebjee, O; Uzunhan, Y; Valeyre, D | 1 |
Ehara, S; Hasegawa, T; Matsumoto, K; Otsuka, K; Sakaguchi, M; Shimada, K; Yoshiyama, M | 1 |
Machida, Y; Maeda, S; Matoba, M; Motono, N; Sagawa, M; Tanaka, M; Tonami, H; Ueda, Y; Ueno, M; Usuda, K; Watanabe, N | 1 |
Álvarez Moro, FJ; García, JR; Sánchez, R | 1 |
Datseris, I; Drougas, D; Georgiou, E; Judson, MA; Kalkanis, A; Kalkanis, D; Vavougios, GD | 1 |
Lu, Y; Sweiss, NJ | 1 |
Hiasa, G; Kazatani, Y; Okayama, H; Takahashi, T | 1 |
Arakawa, J; Fujikawa, A; Kastushika, S; Nagai, T | 1 |
Grutters, JC; Keijsers, RG; Veltkamp, M | 1 |
Hara, T; Ito, H; Kubo, H; Masuda, A; Niitsuma, T; Takeishi, Y; Takenoshita, S; Wada, K; Yamaki, T | 1 |
Emmett, L; Hickey, AJ; Huang, Y; Le, K; Tang, R; Wang, JT; Wang, L | 1 |
Budde, RP; Lam, MG; Scholtens, AM; Verberne, HJ | 1 |
Bertic, M; Tandon, S; Wisenberg, G | 1 |
Crommelin, HA; Grutters, JC; van Moorsel, CH; Vorselaars, AD | 1 |
Bhuniya, S; Mohapatra, PR; Panigrahi, MK; Vivek, KU | 1 |
Arisaka, Y; Nakajima, T; Tokue, A; Yudistiro, R | 1 |
Ananthasubramaniam, K; Cabrera, R | 1 |
Choi, HJ; Gerbaudo, VH; Hyun, H; Joo, J; Kim, CK; Shim, H | 1 |
Lu, Y; Miller, CT; Sweiss, NJ | 1 |
Artiko, V; Grozdic Milojevic, I; Odalovic, S; Saranovic, D; Sobic-Saranovic, D; Videnovic-Ivanov, J | 1 |
Jantunen, E; Partanen, A; Pukkila, S | 1 |
Bokhari, S; Chen, J; DeLuca, A; Morgenstern, R; Weinberg, RL | 1 |
Higo, T; Ikeda, S; Ohtani, K; Uwatoku, T | 1 |
Lu, Y; Patel, D; Sweiss, NJ; Xie, K | 1 |
Abgral, R; Contreras, J; Dweck, MR; Fayad, ZA; Fuster, V; Karakatsanis, N; Kovacic, JC; Lala, A; Mani, V; Miller, M; Narula, J; Padilla, M; Robson, PM; Sanz, J; Trivieri, MG | 1 |
Claessen, AM; Crommelin, HA; Grutters, JC; Hijdra, D; Meek, B; Rijkers, GT; van Moorsel, CH; Vorselaars, AD | 1 |
Ashamalla, M; Grimm, R; Hegener, P; Koutroumpakis, E; McCarthy, L; Mehdi, S | 1 |
Frohman, LP; Ghesani, N; Khodarahmi, I; Turbin, RE | 1 |
Ahmadian, A; Berman, J; Govender, P; Miller, EJ; Pawar, S; Ruberg, FL | 1 |
Birnie, DH; Kandolin, R; Kupari, M; Nery, PB | 1 |
Bateman, TM | 1 |
Bernt, R; Haller, J; Hergan, K; Mirzaei, S; Zandieh, S | 1 |
Inoko, M; Nakane, E; Nakasone, K; Sekihara, T | 1 |
Alavi, A; Cheng, G; Lee, PI | 1 |
Lakhter, V; Manoushagian, SJ; Patil, PV | 1 |
Ali, Z; Aurangabadkar, HU; Bradfield, JS; Kumar, KS; Narasimhan, C; Shelke, AB | 1 |
Dennie, C; Dwivedi, G; Inacio, JR; Juneau, D | 1 |
Grant, C; Lu, Y; Sweiss, NJ; Xie, K | 1 |
Abgral, R; Benigni, P; Feger, B; Robin, P; Salaun, PY | 1 |
Chan, M; Hsiao, E | 1 |
Georgou, E; Judson, MA; Kalkanis, A; Kalkanis, D; Malamitsi, J; Vavougios, GD | 1 |
Chen, ES; Kasper, EK; Kovell, L; Kruse, MJ; Moller, DR; Pomper, MG; Schindler, TH; Solnes, L | 1 |
Bois, JP; Chareonthaitawee, P; Gersh, BJ | 1 |
Bengel, FM; Derlin, T | 1 |
Liu, S; Numani, S; Yang, H | 1 |
Hayashi, H; Katoh, H; Matoh, F; Odagiri, K; Saitoh, T; Sakahara, H; Satoh, H; Shiraki, K; Takehara, Y; Urushida, T | 1 |
Braun, JJ; Charpiot, A; Gentine, A; Imperiale, A; Molard, A; Schultz, P | 1 |
Arena, V; Balleari, E; Cantalupi, D; Carbone, R; Douroukas, A; Ghio, R; Pelosi, E | 1 |
Asaka, M; Hashino, S; Imamura, M; Kahata, K; Kondo, T; Kubota, K; Matsuno, Y; Morita, R; Onozawa, M; Suzuki, S | 1 |
Hisada, T; Ishizuka, T; Kaira, K; Mori, M; Sunaga, N; Yanagitani, N | 1 |
Cadranel, J; de Prost, N; Kerrou, K; Sibony, M; Talbot, JN; Wislez, M | 1 |
Grutters, JC; Keijsers, RG; Oyen, WJ; Ruven, HJ; van den Bosch, JM; van Velzen-Blad, H; Verzijlbergen, FJ | 1 |
Chatziioannou, S; Kolilekas, L; Manali, E; Papiris, S; Rontogianni, D; Triantafillidou, C | 1 |
Bradley, KM; Chowdhury, FU; Gleeson, FV; Sheerin, F | 1 |
Betsuyaku, T; Hattori, T; Inomata, T; Konno, S; Nasuhara, Y; Nishimura, M | 1 |
Keitzer, R; Rothe, JH; Röttgen, R | 1 |
Irioka, T; Mizusawa, H; Ota, K; Saito, K; Tsunemi, T; Watanabe, M; Yamanami, F | 1 |
Hitzler, A; Josse, S; Lahaxe, L; Levesque, H; Marie, I | 1 |
Berding, G; Bolat, S; Dengler, R; Stangel, M; Trebst, C | 1 |
Aiginger, C; Jöst, C; Prosch, H | 1 |
Asopa, RV; Baghel, NS; Basu, S | 1 |
Braun, JJ; Imperiale, A; Riehm, S; Veillon, F | 1 |
Kalra, S; Loe, MJ; Mullan, BP; Subramaniam, RM; Tiegs, RD; Utz, JP | 1 |
Kaira, K | 1 |
Hwangbo, B; Im, HJ; Kim, HJ; Kim, SK; Kim, TS; Kim, W | 1 |
Schauer, M; Theisen, J | 1 |
Baslund, B; Loft, A; Mortensen, J | 1 |
Edet-Samson, A; Lahaxe, L; Marie, I; Vera, P | 1 |
Britton, KA; Katz, JT; Levy, BD; Loscalzo, J; Stevenson, WG | 1 |
Balt, JC; Boom, P; Uijlings, R; Wever, E | 1 |
Koiwa, H; Nishimura, M; Ohira, H; Otsuka, N; Tsujino, I; Yoshinaga, K | 1 |
Sakushima, K; Sasaki, H; Shiga, T; Terae, S; Tsuji-Akimoto, S; Yabe, I; Yashima-Yamada, M | 1 |
Algayres, JP; Bonardel, G; Cambon, A; Carmoi, T; Foehrenbach, H; Gontier, E; Lecoules, S | 1 |
Baba, K; Hayabuchi, N; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mizoguchi, M; Narula, J; Nitta, Y; Tahara, A; Tahara, N | 1 |
Aschoff, P; Oksüz, MO; Pfannenberg, C; Werner, MK | 1 |
Du Bois, RM; Grutters, JC; Keijsers, RG; Lavalaye, J; Thomeer, M; Van Buul, MM; Van Den Bosch, JM; Verzijlbergen, FJ | 1 |
Braun, JJ; Imperiale, A; Namer, IJ; Riehm, S; Veillon, F | 1 |
Arrighi, JA; Brancato, SC | 1 |
Bendstrup, E; Hilberg, O; Hjorthaug, K; Hyldgaard, C; Løvgreen, M | 1 |
Deshayes, E; Grange, JD; Kodjikian, L; Maucort-Boulch, D; Rahmi, A; Seve, P; Varron, L | 1 |
Kataoka, H; Matsunaga, N; Seki, N; Suga, K; Taguchi, T; Yasuhiko, K | 1 |
Graner, M; Kandolin, R; Kivistö, SM; Kupari, M; Lehtonen, J; Salmenkivi, K; Schildt, J | 1 |
Allegri, V; Ambrosini, V; Fanti, S; Fasano, L; Nanni, C; Nava, S; Zompatori, M | 1 |
Rafiei, P; Vijayakumar, V | 1 |
Ohira, H; Tsujino, I; Yoshinaga, K | 1 |
Gámez, C; Mañá, J | 1 |
Manabe, O; Nishimura, M; Ohira, H; Oyama, N; Sato, T; Tsujino, I; Yoshinaga, K | 1 |
Bernit, E; Chagnaud, C; Ebbo, M; Harlé, JR; Mosnier, E; Schleinitz, N; Siles, P; Tintignac, A; Veit, V | 1 |
Berenji, GR; Li, Y | 1 |
Solav, SV | 1 |
Brunken, R; Culver, DA; Isiguzo, M; Tchou, P; Xu, M | 1 |
Altini, C; Asabella, AN; Gatti, P; Iuele, F; Notaristefano, A; Rubini, G | 1 |
Drent, M; Erckens, RJ; Mostard, RL; Nelemans, PJ; van Kroonenburgh, MJ; Verschakelen, JA; Vöö, S; Wijnen, PA | 1 |
de Pont, CD; Drent, M; Mostard, RL; van Kroonenburgh, MJ; Veraart, JC; Voo, SA; Westers-Attema, A | 1 |
Bokhari, S; Chen, S | 1 |
Adams, WM; Bhatnagar, G; Iyengar, S; Maviki, M; Suresh, P; Vardhanabhuti, V; Venkatanarasimha, N | 1 |
Giordano, A; Taralli, S; Treglia, G | 1 |
Ashkenazi, Y; Izbicki, G; Maayan, H; Nagler, A | 1 |
Baslund, B; Graudal, N; Larsen, J; Loft, A; Milman, N; Mortensen, J | 1 |
Drent, M; Geusens, PP; Mostard, RL; Prompers, L; van Kroonenburgh, MJ; Weijers, RE; Wijnen, PA | 1 |
Fukunaga, T; Imamura, T; Kato, J; Kawano, N; Kawano, S; Kitamura, K; Masuyama, H; Mihara, K; Shimao, Y; Toyoda, K; Ueda, A; Yoshimura, Y | 1 |
Beanlands, RS; Birnie, D; Dasilva, J; Dekemp, RA; Gulenchyn, KY; Leung, E; Mylonas, I; Nery, P; Wells, GA; Williams, K; Wisenberg, G; Youssef, G | 1 |
Carruthers, D; Croft, AP; Giovanni, G; Gordon, C; Khair, O; Situnayake, D; Sivaguru, A | 1 |
Hoefnagel, K; Olmos, RV; Stokkel, MP; van der Hiel, B | 1 |
Montini, KM; Tulchinsky, M | 1 |
Manabe, O; Ohira, H; Oyama-Manabe, N; Tamaki, N; Tsutsui, H | 1 |
Bench, T; Brown, DL; Franceschi, D; Matthews, R; Meng, H; Relan, N | 1 |
Bartels, S; Blumstein, N; Glöckner, SC; Görg, T; Heckmann, JG; Kyavar, L; Zimmermann, R | 1 |
Anghinolfi, M; Casalini, A; Gnetti, L; Majori, M; Pavarani, A; Scarascia, A | 1 |
Iino, M; Iizuka, C | 1 |
Artiko, V; Djuric-Stefanovic, A; Grozdic, I; Ilic-Dudvarski, A; Masulovic, D; Obradovic, V; Odalovic, S; Pavlovic, S; Popevic, S; Saranovic, D; Sobic-Saranovic, D; Videnovic-Ivanov, J; Vucinic-Mihailovic, V | 1 |
Arnold, C; Broadley, SA; Meenakshi, M | 1 |
Banks, KP; Clemenshaw, MN; Craun, JB; Moren, RW | 1 |
Grutters, JC; Keijsers, RG; van den Heuvel, DA | 1 |
Baba, Y; Doi, YL; Furuno, T; Kawada, Y; Kitaoka, H; Kubo, T; Matsumura, Y; Okawa, M; Sugiura, T; Yamanaka, S; Yamasaki, N | 1 |
Arai, M; Chiba, T; Imazeki, F; Inoue, M; Kanai, F; Kanda, T; Ogasawara, S; Ogawa, M; Sugiyama, H; Yokosuka, O; Yokota, H; Zen, Y | 1 |
Brown, RK; Corbett, JR; Dvorak, RA; Kazerooni, EA; Lobert, P; Wong, KK | 1 |
Brillet, PY; Naggara, N; Nunes, H; Ouvrier, MJ; Pop, G; Soussan, M; Valeyre, D; Weinmann, P | 1 |
Aga, F; Dobashi, H; Nishiyama, Y; Ono, Y; Tanaka, K; Yamamoto, Y | 1 |
Alavi, A; Kwee, TC; Torigian, DA | 1 |
Archie, DS; Freire, AX; Kadaria, D; SultanAli, I; Weiman, DS; Zaman, MK | 1 |
Beanlands, RS; Birnie, D; Cocker, MS; DaSilva, J; deKemp, RA; Leung, E; Mc Ardle, BA; Nery, PB; Ohira, H | 1 |
Grutters, JC; Keijsers, RG; Vorselaars, AD | 1 |
Hiroe, M; Ito, K; Kubota, K; Minaminoto, R; Morooka, M; Okazaki, O | 1 |
Lee, VK; Loo, SW; Lu, SJ | 1 |
Tada, A | 1 |
Bakshi, R; Dubey, N; Mechtler, LL; Miletich, RS; Wasay, M | 1 |
Husso-Saastamoinen, M; Kuikka, JT; Sohlberg, A | 1 |
Delbeke, D; Fordice, S; Lamar, R; Ludwig, V; Martin, WH | 1 |
Garcia, CA; Rosenberg, RJ; Spencer, RP | 1 |
Akioka, K; Shirai, N; Takagi, M; Takeuchi, K; Yamagishi, H; Yoshikawa, J; Yoshiyama, M | 1 |
Arici, M; Sood, R; Spencer, RP; Vento, JA | 1 |
Aberg, C; Amorosi, E; Kramer, E; Moran, V; Ponzo, F; Raphael, B | 1 |
Fujita, T; Horita, Y; Kaku, B; Kanaya, H; Ohka, T; Uno, Y; Yamazaki, T | 1 |
Bekkers, SC; Gorgels, AP; Smedema, JP; Snoep, G; van Kroonenburgh, MJ | 1 |
Arai, M; Endo, K; Iso, T; Iwasaki, T; Kurabayashi, M; Okumura, W; Oriuchi, N; Suzuki, T; Toyama, T; Yokoyama, T | 1 |
Cerfolio, RJ; Chen, VK; Desmond, R; Eloubeidi, MA; Ojha, B; Syed, S | 1 |
DeYoung, BR; Funk, GF; Goldstein, DP; Graham, MM; Yao, M | 1 |
Alavi, A; Cheng, E; Kumar, R; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
Ikeda, D; Ishimaru, S; Ito, N; Kamigaki, M; Nishimura, M; Ohira, H; Sakaue, S; Takei, T; Tamaki, N; Tsujino, I; Tsukamoto, E | 1 |
Iwado, Y; Kohno, M; Ohmori, K; Senda, S; Shinomiya, K | 1 |
Hirabayashi, H; Maeda, J; Matsuda, H; Ohta, M | 1 |
Braido, F; Canonica, GW; Cavallero, GB; Genovese, E; Gozzoli, L; Perotti, L; Stea, F; Zolezzi, A | 1 |
Arai, M; Endo, M; Goto, K; Hasegawa, A; Kaneko, Y; Kurabayashi, M; Morita, M; Nakano, A; Okamoto, E; Sasamoto, T; Suguta, M; Umezawa, K | 1 |
Abreo, F; Behm, W; Bozeman, C; Heldmann, M; Minagar, A; Reddy, MP; Welman, G | 1 |
Bonenkamp, JJ; Bulten, J; Hendrickx, BW; Oyen, WJ; van Herpen, CM | 1 |
Ishimaru, S; Nishimura, M; Oyama, N; Sakaue, S; Takei, T; Tamaki, N; Tsujino, I; Tsukamoto, E | 1 |
Bybel, B; Guglielmi, AN; Kim, BY; Slifkin, N | 1 |
Avram, AM; Kalemkerian, GP; Mackie, GC; Schneider, BJ; Shulkin, BL | 1 |
Geukens, R; Reenaers, V; Smedema, JP | 1 |
Hosokawa, R; Kanao, S; Kimura, T; Kita, T; Kubo, S; Tadamura, E; Togashi, K; Yamamuro, M | 1 |
Jacobs, M; Mantil, J; Ng, D | 1 |
Fukunaga, K; Iwado, Y; Nishiyama, Y; Ohkawa, M; Satoh, K; Takinami, H; Yamamoto, Y | 1 |
Nguyen, BD | 1 |
Cheng, CY; Cherng, SC; Fan, YM; Hsu, HH; Huang, WS; Lee, SC; Shen, DH | 1 |
Brunken, RC; Culver, DA; Pandya, C; Schoenhagen, P; Tchou, P | 1 |
Brucker-Davis, F; Bständig, B; Fenichel, P; Kunstmann, L; Mouroux, J; Rigot, P | 1 |
Bai, RJ; Gao, S; Li, YJ; Zhang, Y | 1 |
Endo, K; Hisada, T; Ishizuka, T; Kaira, K; Mori, M; Oriuchi, N; Otani, Y; Sunaga, N; Yanagitani, N | 1 |
Billotey, C; Bouhour, F; Broussolle, C; Dufour, JF; Sève, P; Streichenberger, N | 1 |
Ceriani, L; Gallino, A; Györik, S; Menafoglio, A; Wyttenbach, R | 1 |
Aide, N; Benayoun, M; Cadranel, J; Kerrou, K; Khalil, A; Talbot, JN | 1 |
Chen, JY; Luh, SP; Tsao, TC; Wang, YT; Wu, TC | 1 |
Halkar, RK; Kost, CB; Reilly, TB; Schuster, DM; Starsiak, MD | 1 |
Clarençon, F; Fernandez, P; Feydy, A; Hourseau, M; Kerrou, K; Lebreton, C; Marchand-Adam, S; Schouman-Claeys, E; Silbermann-Hoffman, O | 1 |
Aras, G; Küçük, NO; Ozkan, E | 1 |
Hibino, T; Hiramitsu, S; Ichiro Morimoto, S; Kako, N; Kato, K; Kato, Y; Kuroda, M; Mizoguchi, Y; Morikawa, M; Oguri, M; Yajima, K; Yokoi, K | 1 |
Almeida, O; Iannuzzi, MC; Lu, P; Machac, J; Padilla, ML; Teirstein, AS | 1 |
Ishimaru, S; Miura, M; Nishimura, M; Ohira, H; Oyama, N; Sakaue, S; Takei, T; Tamaki, N; Tsujino, I; Tsukamoto, E | 1 |
Aigner, RM; Bisail, B; Lanz, H; Prager, E; Schwarz, T; Sorantin, E; Wehrschuetz, M; Woltsche, M | 1 |
Subbiah, V | 1 |
Aquino, SL; Gibbons, FK; O'Donnell, WJ; Prabhakar, HB; Rabinowitz, CB; Shepard, JA | 1 |
Chew, FS; Prabhakar, HB; Rabinowitz, CB | 1 |
Fukuda, H; Kaneta, T; Kinomura, S; Takahashi, S; Takanami, K; Yamada, S; Yamada, T | 1 |
Bergot, E; Paparel, P; Zalcman, G | 1 |
Mulligan, ME; Smith, S; Talmi, D | 1 |
Braun, JJ; Constantinesco, A; Imperiale, A; Kessler, R | 1 |
Chida, K; Inui, N; Miwa, S; Miyazaki, H; Suda, T; Torizuka, T | 1 |
Lewis, PJ; Salama, A | 1 |
Alavi, A; Buchpiguel, CA; Loessner, A | 1 |
Larson, SM | 1 |
Ide, M; Mitomi, T; Ogawa, J; Shohtsu, A; Suzuki, Y; Takagi, S; Yasuda, S | 1 |
Mañá, J | 1 |
Conti, PS; Muggia, FM | 1 |
Aoyagi, K; Endo, K; Hatori, T; Inoue, T; Iwasaki, T; Matsubara, K; Miyajima, A; Nagai, R; Okumura, W; Otake, H; Sato, H; Seki, R; Suzuki, T; Toyama, T; Ueda, T | 1 |
Ishida, Y; Nakatani, S; Tachibana, T | 1 |
Kato, K; Kobayashi, A; Oriuchi, N; Shinjyo, Y; Shinozaki, T; Takagishi, K; Watanabe, H | 1 |
Kaiser, KP; Taaleb, K; Wieler, H | 1 |
Hoegerle, S; Joe, A; Moser, E | 1 |
Akaizawa, T; Fukuda, H; Itoh, M; Kubota, K; Ono, S; Ozaki, K; Tashiro, M; Yamada, K; Yamaguchi, K | 1 |
Harper, PG; Karapetis, CS; Strickland, AH; van der Walt, JD; Yip, D | 1 |
Alavi, A; Zhuang, H | 1 |
Harada, T; Hiroi, Y; Murakawa, Y; Nagai, R; Nakamura, F; Sakata, M; Takeda, N; Yokoyama, I | 1 |
74 review(s) available for fluorodeoxyglucose f18 and Sarcoidosis
Article | Year |
---|---|
Potential novel imaging targets of inflammation in cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2022 |
Utilization of cardiac imaging in sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2022 |
Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity | 2022 |
The role of PET in the management of sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prospective Studies; Sarcoidosis | 2022 |
[Hybrid PET/MRI for inflammatory cardiomyopathy].
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2022 |
Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon | 2022 |
Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity | 2023 |
Cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart; Humans; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2023 |
Prognostic Value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
Topics: Adult; Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Myocarditis; Prognosis; Sarcoidosis | 2023 |
FDG PET/CT Imaging of Sarcoidosis.
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2023 |
Radionuclide Assessment of Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Sarcoidosis | 2023 |
Personalized medicine in sarcoidosis: unravelling biomarkers for targeted care.
Topics: Biomarkers; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Precision Medicine; Sarcoidosis | 2023 |
Topics: Fluorodeoxyglucose F18; Granuloma; Humans; Positron Emission Tomography Computed Tomography; Sarcoidosis; Tattooing | 2023 |
Cardiac Sarcoidosis.
Topics: Canada; Cardiomyopathies; Contrast Media; Death, Sudden, Cardiac; Defibrillators, Implantable; Fluorodeoxyglucose F18; Gadolinium; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Sarcoidosis; Treatment Outcome | 2019 |
FDG-PET Scan in Sarcoidosis: Clinical and Imaging Indications.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis | 2019 |
The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis.
Topics: Cardiac Imaging Techniques; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2019 |
PET/Computed Tomography in Pulmonary and Thoracic Inflammatory Diseases (Including Cardiac Sarcoidosis): The Current Role and Future Promises.
Topics: Arteritis; Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lupus Erythematosus, Systemic; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Thoracic Diseases | 2020 |
The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis.
Topics: Cardiomyopathies; Endocarditis; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Myocarditis; Pericarditis; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sarcoidosis | 2021 |
Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Time Factors | 2020 |
Pulmonary sarcoidosis: a clinical update
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sarcoidosis, Pulmonary | 2020 |
The role of cardiac magnetic resonance in diagnosis of cardiac sarcoidosis.
Topics: Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2021 |
Diagnosis of cardiac sarcoidosis: a primer for non-imagers.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2022 |
The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sarcoidosis | 2021 |
PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).
Topics: Cardiomyopathies; Cardiovascular Diseases; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Cardiac Involvement in Sarcoidosis: Evolving Concepts in Diagnosis and Treatment.
Topics: Fluorodeoxyglucose F18; Glucocorticoids; Heart Diseases; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Sarcoidosis; Tomography, X-Ray Computed | 2017 |
Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by
Topics: Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2017 |
Variances of dietary preparation for suppression of physiological
Topics: Animals; Australia; Calcium Channel Blockers; Diet; Fluorodeoxyglucose F18; Heart; Heart Diseases; Heparin; Humans; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2020 |
Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.
Topics: Algorithms; Cardiology; Cardiomyopathies; Disease Progression; Fluorodeoxyglucose F18; Heart Failure; Humans; Immunosuppressive Agents; Inflammation; Nuclear Medicine; Positron-Emission Tomography; Prognosis; Sarcoidosis | 2019 |
Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sarcoidosis; Sensitivity and Specificity | 2020 |
PET/CT Evaluation of Cardiac Sarcoidosis.
Topics: Biomedical Technology; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2019 |
Potential Role of PET in Assessing Ventricular Arrhythmias.
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Chagas Cardiomyopathy; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis | 2019 |
The role of positron emission tomography in the assessment of cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2019 |
Recommendations for
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Japan; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Sarcoidosis | 2019 |
Imaging in Suspected Cardiac Sarcoidosis: A Diagnostic Challenge.
Topics: Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Sarcoidosis | 2020 |
(18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Image Interpretation, Computer-Assisted; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
FDG PET imaging in sarcoidosis.
Topics: Chronic Disease; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Positron-Emission Tomography; Sarcoidosis | 2013 |
[Application of fluorine-18 fluorodeoxyglucose-positron emission tomography in the diagnosis and therapy of patients with sarcoidosis].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Biomarkers; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Advanced imaging of cardiac sarcoidosis.
Topics: Cardiomyopathies; Clinical Trials as Topic; Fluorodeoxyglucose F18; Heart Diseases; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2014 |
The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Topics: Adult; Arrhythmias, Cardiac; Cardiomyopathies; Echocardiography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Atypical Presentation of Sarcoidosis on ¹⁸F-FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Image Enhancement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases.
Topics: Animals; Arteritis; Atherosclerosis; Fluorodeoxyglucose F18; Heart Diseases; Humans; Insurance, Health; Japan; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sarcoidosis | 2014 |
Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.
Topics: Biopsy; Fluorodeoxyglucose F18; Glucocorticoids; Heart Diseases; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Heart Diseases; Humans; Infections; Lung Diseases; Mediastinal Diseases; Multimodal Imaging; Myocardium; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Diseases; Thoracic Diseases; Thoracic Injuries; Thoracic Vertebrae; Thorax; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Cardiac Hot Spot Imaging With (18)FDG.
Topics: Animals; Diagnostic Imaging; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Sarcoidosis | 2014 |
Assessment of cardiac sarcoidosis with advanced imaging modalities.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging, Cine; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2014 |
Imaging of Sarcoidosis.
Topics: Fluorodeoxyglucose F18; Gallium; Granuloma; Heart; Humans; Lung; Magnetic Resonance Imaging; Multidetector Computed Tomography; Prognosis; Pulmonary Fibrosis; Radiography, Thoracic; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis | 2015 |
Diagnosis of Sarcoidosis.
Topics: Biopsy, Fine-Needle; Bronchoscopy; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma; Granulomatous Disease, Chronic; Humans; Lung; Lymphatic Diseases; Radiography, Thoracic; Radionuclide Imaging; Radiopharmaceuticals; Respiratory Function Tests; Sarcoidosis; Tomography, X-Ray Computed | 2015 |
FDG-PET/CT in Infectious and Inflammatory Diseases.
Topics: Arthritis, Rheumatoid; Bacterial Infections; Bone Diseases; Endocarditis; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Inflammation; Inflammatory Bowel Diseases; Multimodal Imaging; Positron-Emission Tomography; Psoriasis; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Vasculitis; Venous Thromboembolism | 2014 |
Advances in imaging for diagnosis and management of cardiac sarcoidosis.
Topics: Cardiac Imaging Techniques; Cardiomyopathies; Cause of Death; Disease-Free Survival; Early Diagnosis; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Image Interpretation, Computer-Assisted; Immunosuppressive Agents; Magnetic Resonance Imaging, Cine; Male; Mass Screening; Positron-Emission Tomography; Prognosis; Radiographic Image Enhancement; Risk Assessment; Sarcoidosis; Severity of Illness Index; Survival Analysis | 2015 |
Bone and bone marrow involvement in sarcoidosis.
Topics: Adult; Biopsy; Bone Diseases; Bone Marrow; Bone Marrow Diseases; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Humerus; Hydroxychloroquine; Ilium; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Patella; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Whole Body Imaging | 2015 |
Advances in radionuclide imaging of cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomography; Prognosis; Sarcoidosis; Tomography, Emission-Computed, Single-Photon | 2015 |
Chest Imaging.
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2015 |
Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis.
Topics: Anticoagulants; Cardiomyopathies; Fluorodeoxyglucose F18; Heparin; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Regression Analysis; ROC Curve; Sarcoidosis; Sensitivity and Specificity | 2016 |
[Sarcoidosis-lymphoma syndrome].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Syndrome; Tomography, X-Ray Computed | 2016 |
[PET/CT: Molecular Imaging and Theranostics for Radionuclide Therapy].
Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided; Sarcoidosis; Theranostic Nanomedicine; Treatment Outcome | 2017 |
[Use of positron emission tomography in sarcoidosis].
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2011 |
¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocardium; Positron-Emission Tomography; Sarcoidosis | 2011 |
Molecular imaging in sarcoidosis.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Extra-pulmonary manifestations of sarcoidosis.
Topics: Cardiomyopathies; Central Nervous System Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Musculoskeletal Diseases; Myocardial Perfusion Imaging; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Urologic Diseases | 2012 |
Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sarcoidosis; Severity of Illness Index; Whole Body Imaging | 2011 |
Sarcoidosis and lymphoma: case series and literature review.
Topics: Adolescent; Adult; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2011 |
The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience.
Topics: Canada; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; ROC Curve; Sarcoidosis | 2012 |
Imaging the inflammatory activity of sarcoidosis.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunosuppressive Agents; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiography, Thoracic; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT.
Topics: Adipose Tissue, Brown; Artifacts; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Atria; Heart Diseases; Heart Ventricles; Humans; Leukemia; Lymphoma; Multimodal Imaging; Myocardium; Organ Specificity; Papillary Muscles; Pericarditis; Pericardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Nononcological applications of positron emission tomography for evaluation of the thorax.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Idiopathic Interstitial Pneumonias; Infections; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Respiratory Distress Syndrome; Sarcoidosis; Thoracic Diseases; Thorax | 2013 |
The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.
Topics: Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis | 2013 |
[67Gallium whole body scintigraphy and single photon emission computed tomography(SPECT) in sarcoidosis].
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Sarcoidosis; Thallium Radioisotopes; Tomography, Emission-Computed | 1997 |
18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.
Topics: Acquired Immunodeficiency Syndrome; Diagnosis, Differential; False Positive Reactions; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Osteomyelitis; Prosthesis-Related Infections; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis | 2002 |
11 trial(s) available for fluorodeoxyglucose f18 and Sarcoidosis
Article | Year |
---|---|
Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathies; Case-Control Studies; Cohort Studies; Cost of Illness; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Immunosuppression Therapy; Incidence; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sarcoidosis; Tachycardia, Ventricular | 2020 |
What Is the Optimal Method on Myocardial Suppression in FDG PET/CT Evaluation of Cardiac Sarcoidosis?
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2021 |
How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body
Topics: Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Sarcoidosis; Whole Body Imaging | 2018 |
Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Cross-Over Studies; Fatty Acids, Nonesterified; Female; Fluorodeoxyglucose F18; Heparin; Humans; Insulin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis; Somatostatin | 2013 |
Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.
Topics: Biological Transport; Cardiomyopathies; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Use of PET-CT for the assessment of treatment results in patients with sarcoidosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Male; Metabolic Clearance Rate; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Treatment Outcome | 2017 |
The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
Topics: Adult; Aged; Chronic Disease; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Topics: Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Granuloma; Histiocytosis; Histoplasmosis; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Silicosis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Urinary Bladder Neoplasms | 2005 |
[Usefulness of 18F-FDG PET for diagnosis of cardiac sarcoidosis].
Topics: Adult; Aged; Cardiomyopathies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoidosis; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Advantage of delayed whole-body FDG-PET imaging for tumour detection.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Mesothelioma; Neoplasms; Radiopharmaceuticals; Sarcoidosis; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2001 |
443 other study(ies) available for fluorodeoxyglucose f18 and Sarcoidosis
Article | Year |
---|---|
Symptomatic isolated axillary lymph node sarcoidosis: an unusual presentation.
Topics: Aged, 80 and over; Axilla; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Sarcoidosis | 2021 |
Neurosarcoidosis pathologically diagnosed via biopsy of a normal-sized inguinal lymph node with fluorodeoxyglucose accumulation on positron emission tomography/computed tomography in a patient with a history of brain Ewing's sarcoma.
Topics: Biopsy; Brain; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Sarcoidosis; Sarcoma, Ewing | 2022 |
The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2022 |
Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging.
Topics: Aged; Biomarkers; Case-Control Studies; Cytokines; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Immunosuppressive Agents; Inflammation; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Interleukin-2; Receptors, Tumor Necrosis Factor; Risk Assessment; Sarcoidosis; Severity of Illness Index; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2021 |
FDG PET imaging in suspected cardiac sarcoidosis: diagnosis vs. prognosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis | 2022 |
Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2022 |
Delayed
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
[
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2022 |
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Inflammation; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome | 2022 |
Pulmonary Arterial
Topics: Fluorodeoxyglucose F18; Humans; Hypertension, Pulmonary; Positron-Emission Tomography; Predictive Value of Tests; Sarcoidosis | 2022 |
[Systemic sarcoidosis developed after chemoradiotherapy for localized thyroid diffuse large B-cell lymphoma].
Topics: Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis; Thyroid Gland | 2021 |
Löfgren Syndrome on 18F-FDG PET/CT: An Acute Manifestation of Sarcoidosis.
Topics: Erythema Nodosum; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2022 |
Muscular sarcoidosis in the eyes of
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis | 2022 |
The challenging management of cardiac involvement in systemic sarcoidosis.
Topics: Adult; Atrioventricular Block; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Positron-Emission Tomography; Sarcoidosis | 2022 |
Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Biomarkers; Cardiomyopathies; Death, Sudden, Cardiac; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Myocarditis; Oxidative Stress; Prospective Studies; Risk Factors; Sarcoidosis; Tachycardia, Ventricular | 2022 |
Extensive Biventricular Cardiac Sarcoidosis Detected on FDG PET/CT Using a 72-Hour Ketogenic Diet Preparation Protocol.
Topics: Cardiomyopathies; Contrast Media; Diet, Ketogenic; Fluorodeoxyglucose F18; Gadolinium; Humans; Male; Middle Aged; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2022 |
All that glitters is not sarcoidosis: Importance of systematic review of
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
Spinal cord sarcoidosis in Japan: utility of cerebrospinal fluid examination and nerve conduction study for diagnosis and prognosis prediction.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Neural Conduction; Prognosis; Receptors, Interleukin-2; Sarcoidosis; Spinal Cord | 2022 |
Endobronchial ultrasound-guided transbronchial needle aspiration facilitating diagnosis of sarcoidosis in a breast cancer patient with multiple lymphadenopathy: a case report.
Topics: Aged; Breast Neoplasms; Bronchoscopy; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphadenopathy; Mastectomy; Mediastinum; Receptors, Interleukin-2; Sarcoidosis | 2022 |
Renal sarcoidosis: Local renal turgescence, hypermetabolic
Topics: Fluorodeoxyglucose F18; Granuloma; Humans; Kidney; Nephritis, Interstitial; Sarcoidosis | 2022 |
Not All That Glitters Is Sarcoidosis: Septal Perforator Myocardial Infarction Mimicking Isolated Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2022 |
Analysis of misdiagnosis and 18F-FDG PET/CT findings of lymph node tuberculosis.
Topics: Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tuberculosis, Lymph Node | 2022 |
Utility of Updated Japanese Circulation Society Guidelines to Diagnose Isolated Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Japan; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2022 |
18F-FMISO PET/CT: a new promising radiotracer for cardiac sarcoidosis and extracardiac involvement?
Topics: Fluorodeoxyglucose F18; Humans; Misonidazole; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2022 |
Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2023 |
The Onset of Sarcoidosis After COVID-19 Vaccination Revealed by the 18 F-FDG PET.
Topics: Adult; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoidosis; Vaccination | 2022 |
Successful treatment of cardiac sarcoidosis based on clinical suspicion and advanced cardiac imaging: A case report.
Topics: Aged; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Myocarditis; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2022 |
Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias.
Topics: Adalimumab; Arrhythmias, Cardiac; Atrioventricular Block; Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Inflammation; Male; Middle Aged; Mycophenolic Acid; Myocarditis; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2022 |
Incidence and Predictors of Atrial Fibrillation in Cardiac Sarcoidosis: A Multimodality Imaging Study.
Topics: Atrial Fibrillation; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Incidence; Inflammation; Middle Aged; Myocarditis; Predictive Value of Tests; Sarcoidosis; Tomography, X-Ray Computed | 2022 |
Atrial Fibrillation and Cardiac Sarcoidosis: The Aperture Widens Through the Lens of FDG-PET Imaging.
Topics: Atrial Fibrillation; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis | 2022 |
FDG PET of Isolated Right Ventricular Sarcoidosis.
Topics: Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2023 |
FDG uptake patterns in isolated and systemic cardiac sarcoidosis.
Topics: Cardiomyopathies; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2023 |
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis | 2022 |
Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Immunosuppression Therapy; Male; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Sarcoidosis | 2022 |
Treating Myocardial Inflammation in Cardiac Sarcoidosis: Why, With What, and for How Long?
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis | 2022 |
Serial assessment of cardiac involvement in sarcoidosis by delayed
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
Access to cardiac PET/CT by sarcoidosis patients and cost-effectiveness analysis of cardiac PET/MR compared to the standard of care.
Topics: Cost-Effectiveness Analysis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quality of Life; Sarcoidosis; Standard of Care | 2023 |
PET-CT in the diagnosis of cardiac and pulmonary sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sarcoidosis, Pulmonary | 2023 |
Utility of very long fasting to detect myocardial inflammation in cardiac sarcoidosis.
Topics: Cardiomyopathies; Fasting; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Sarcoidosis | 2023 |
Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Heart Arrest; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Sarcoidosis | 2023 |
Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Methotrexate; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2023 |
The Mechanism and Natural History of Mitral Regurgitation in Cardiac Sarcoidosis.
Topics: Fluorodeoxyglucose F18; Humans; Mitral Valve Insufficiency; Myocarditis; Sarcoidosis; Severity of Illness Index; Stroke Volume; Ventricular Function, Left | 2023 |
Diagnostic yield of whole-body
Topics: Adult; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2023 |
Volume-based 18 F-FDG PET analysis of cardiac sarcoidosis using the descending aorta as a reference tissue.
Topics: Aorta, Thoracic; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
Impact of respiratory gating and ECG gating on
Topics: Cytomegalovirus Infections; Electrocardiography; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2023 |
Optimal Timing of Serial
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2023 |
Linking cardiac and extracardiac sarcoidosis and their clinical outcome:
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
What is this image? 2023 Image 6 result:
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
Sex differences in cardiac sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Sarcoidosis; Sex Characteristics; Tachycardia, Ventricular | 2023 |
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
Topics: Atrioventricular Block; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Myocardial Perfusion Imaging; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2023 |
Diagnostic values of delayed additional FDG PET/CT scan in the evaluation of cardiac sarcoidosis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed | 2023 |
Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
An International Survey of Current Clinical Practice in the Treatment of Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis | 2023 |
Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis.
Topics: Adalimumab; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Infliximab; Myocarditis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Tumor Necrosis Factor-alpha | 2023 |
[ 18 F] FDG PET/CT Imaging in a Rare Case of Sarcoidosis With Involvement of Epididymis.
Topics: Epididymis; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2023 |
Isolated muscular sarcoidosis presenting as hypercalcaemic renal failure.
Topics: Fluorodeoxyglucose F18; Granuloma; Humans; Hypercalcemia; Male; Myositis; Renal Insufficiency; Sarcoidosis | 2023 |
Typical trident sign and cardiac involvement in a patient suspected to Sarcoidosis despite negative whole-body FDG-PET: a case report.
Topics: Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study.
Topics: Cardiomyopathies; Coronary Circulation; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis | 2019 |
The Utility of Whole Body
Topics: Australia; Cardiomyopathies; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcoidosis | 2020 |
Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.
Topics: Adalimumab; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Cardiomyopathies; Deprescriptions; Drug Therapy, Combination; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sarcoidosis; Treatment Outcome | 2019 |
Sarcoid-like Histiocytic Proliferations in Patients With Lymphoma Can Be FDG-avid Concerning for Refractory or Recurrent Disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Histiocytes; Humans; Immunohistochemistry; Lymphoma; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisolone; Sarcoidosis; Vincristine | 2019 |
18F-FDG PET/CT of Multiorgan Sarcoid-Like Reaction During Anti-PD-1 Treatment for Melanoma.
Topics: Antibodies; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Sarcoidosis | 2019 |
The rate of myocardial perfusion recovery after steroid therapy and its implication for cardiac events in cardiac sarcoidosis and primarily preserved left ventricular ejection fraction.
Topics: Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Circulation; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Heart Diseases; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Prednisolone; Radiopharmaceuticals; Recovery of Function; Retrospective Studies; Sarcoidosis; Stroke Volume | 2021 |
Case Report: Sarcoidosis mimicking head and neck cancer progression.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sarcoidosis | 2019 |
Detection of Active Inflammation Status Around Ventricular Aneurysms in Patients With Cardiac Sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Male; Middle Aged; Myocarditis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2019 |
Dual Time-Point 18F-FDG PET/CT in Spinal Sarcoidosis: A Single Institution Case Series.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Cord Diseases; Spinal Diseases | 2019 |
Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
Topics: Adult; Biopsy; Cardiomyopathies; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiography, Thoracic; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity | 2020 |
Myocardial perfusion imaging in cardiac sarcoidosis: A "sine qua non" for prognosis assessment?
Topics: Fluorodeoxyglucose F18; Heart Diseases; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sarcoidosis | 2021 |
Cardiac sarcoidosis: the complementary role of 18F-FDG PET and MRI.
Topics: Adult; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Steroids; Treatment Outcome | 2020 |
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Japan; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sarcoidosis | 2021 |
Prognostic Value of
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2020 |
Effect of Corticosteroid Dose and Duration on 18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis.
Topics: Adrenal Cortex Hormones; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Sarcoidosis; Time Factors; Treatment Outcome | 2020 |
FDG-PET Imaging in Sarcoidosis.
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis | 2019 |
Hybrid Imaging in Evaluation of Abdominal Sarcoidosis.
Topics: Abdomen; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2019 |
Diagnostic Performance of
Topics: Adult; Aged; Disease Management; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2019 |
Re: Cutaneous Manifestation of Sarcoidosis in Lower-Back Tattoo With Increased Uptake of 18F-FDG.
Topics: Back; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sarcoidosis; Tattooing | 2020 |
[Update Sarcoidosis].
Topics: Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Lung; Positron-Emission Tomography; Sarcoidosis | 2020 |
2020 vision: New insights on hypoxia imaging to assess cardiac and extra-cardiac active inflammatory sarcoidosis.
Topics: Fluorodeoxyglucose F18; Heart; Humans; Hypoxia; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Proliferation imaging with
Topics: Adult; Aged; Carbon Radioisotopes; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Thionucleosides; Thymidine | 2021 |
Normal variant left ventricular lateral wall 18FDG uptake in cardiac sarcoid evaluations.
Topics: Adult; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Acute inflammatory pericarditis secondary to cardiac sarcoidosis evaluated by 18F-fluorodeoxyglucose PET/CT imaging.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Middle Aged; Pericarditis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Colon Sarcoidosis Mimicking Cancer at 18F-FDG PET/CT.
Topics: Aged; Colonic Neoplasms; Colonoscopy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2020 |
A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G4-Related Disease; Lymph Nodes; Lymphadenopathy; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Young Adult | 2020 |
Prevalence of atrial FDG uptake and association with atrial arrhythmias in patients with cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prevalence; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2020 |
Whole-Body 18F-FDG PET-CT in the Diagnosis of Neurosarcoidosis.
Topics: Adult; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2020 |
Prevalence, distribution and clinical significance of joints, muscles and bones in sarcoidosis: an
Topics: Adult; Bone and Bones; Female; Fluorodeoxyglucose F18; Humans; Joints; Male; Middle Aged; Muscles; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2020 |
Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2022 |
Asymptomatic tiny subcutaneous eruptions in a patient with sarcoid neuropathy: the effectiveness of fluorine-18 fluorodeoxyglucose positron emission tomography for targeting safe biopsy sites.
Topics: Asymptomatic Diseases; Biopsy; Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Skin Diseases; Subcutaneous Tissue; Whole Body Imaging | 2019 |
18F-FDG PET/CT Findings in a Patient With Neurosarcoidosis.
Topics: Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2020 |
Left ventricular thrombus on
Topics: Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Thrombosis | 2021 |
A Patient with Cardiac Sarcoidosis in Whom an Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxyglucose and Sustained Ventricular Tachycardia Recurred 3.5 Years after Discontinuing Oral Corticosteroid Therapy.
Topics: Adrenal Cortex Hormones; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Sarcoidosis; Tachycardia, Ventricular | 2020 |
Rare Case of Testicular Sarcoidosis Detected on FDG PET/CT in a Patient With PUO.
Topics: Aged; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoidosis; Testicular Diseases | 2020 |
Relevance of concurrent hypercalcemia in ureteric sarcoidosis complicated with bladder urothelial carcinoma: a case report.
Topics: Carcinoma, Transitional Cell; Cystoscopy; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hydronephrosis; Hypercalcemia; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Renal Insufficiency; Sarcoidosis; Tomography, X-Ray Computed; Ureteral Diseases; Ureteral Neoplasms; Ureteroscopy; Urinary Bladder Neoplasms | 2020 |
Diagnosis of isolated cardiac sarcoidosis based on new guidelines.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2020 |
68Ga-DOTATOC PET for Treatment Efficacy Evaluation of Cardiac Sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis; Sensitivity and Specificity; Treatment Outcome | 2020 |
Is quantitative fluorine-18 fluorodeoxyglucose PET image analysis the key to Identify cardiac sarcoidosis?
Topics: Cardiomyopathies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2022 |
Simultaneous use of FDG-18 and
Topics: Adenocarcinoma; Aged; Anthracosis; Biopsy; Bronchoscopy; Citrates; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium; Humans; Lung; Male; Neoplasms; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2020 |
Bone Marrow Sarcoidosis with Pancytopenia and Renal Failure Presenting as Fever of Unknown Origin: The Pivotal Role of 18F-FDG PET/CT in Lesion Detection.
Topics: Adrenal Cortex Hormones; Biopsy; Bone Marrow; Bone Marrow Diseases; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lung; Male; Middle Aged; Pancytopenia; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Renal Insufficiency; Sarcoidosis | 2021 |
Benefits of [
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis | 2022 |
De Novo Presentation of Sarcoidosis on Restaging FDG PET/CT in Rectal Carcinoma With Self-resolution.
Topics: Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Rectal Neoplasms; Remission, Spontaneous; Sarcoidosis | 2021 |
Clinicoradiological dissociation in sarcoid myelopathy.
Topics: Aged; Biopsy; Brain; Central Nervous System Diseases; Eye Pain; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hypesthesia; Lymph Nodes; Lymphadenopathy; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Paresthesia; Peripheral Nervous System Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Cord; Spinal Cord Diseases | 2020 |
Regarding "Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential
Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2021 |
Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Tachycardia, Ventricular; Ventricular Fibrillation | 2020 |
18F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PET.
Topics: Aged; Biological Transport; Fluorodeoxyglucose F18; Humans; Inflammation; Large Neutral Amino Acid-Transporter 1; Male; Positron-Emission Tomography; Sarcoidosis; Sensitivity and Specificity | 2020 |
Diagnostic utility of fusion
Topics: Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2022 |
Novel dietary protocol prior to 18F-fluorodeoxyglucose positron emission tomography to evaluate for cardiac sarcoidosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Feasibility of
Topics: Adolescent; Adult; Aged; Cardiomyopathies; Endocarditis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Whole Body Imaging; Young Adult | 2021 |
Excellent suppression of physiological myocardial FDG activity in patients with cardiac sarcoidosis.
Topics: Fluorodeoxyglucose F18; Humans; Myocardium; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2021 |
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2022 |
Sequential FDG-PET in the management of multiorgan sarcoidosis.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tachycardia, Ventricular | 2021 |
Tiger man sign in sarcoid myopathy.
Topics: Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Middle Aged; Muscular Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Interleukin-2; Sarcoidosis | 2021 |
Diagnostic utility of 68Ga-citrate and 18FDG PET/CT in sarcoidosis patients.
Topics: Citrates; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2020 |
Unusual presentation of sarcoidosis, requiring a positron emission tomography/CT (PET/CT) for diagnosis.
Topics: Acute Kidney Injury; Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Hypercalcemia; Lymph Nodes; Male; Parathyroid Hormone; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2021 |
Pre-Treatment Myocardial
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Immunosuppression Therapy; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2021 |
Added value gated PET with phase analysis for the detection of scar burden and prognostication in cardiac sarcoidosis?
Topics: Cardiomyopathies; Cicatrix; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis | 2022 |
Effectiveness and safety of infliximab in cardiac Sarcoidosis.
Topics: Cardiomyopathies; Cohort Studies; Fluorodeoxyglucose F18; Humans; Infliximab; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcoidosis; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2021 |
A Case of Rapidly Progressing Granulomatous Myocarditis: What Is the Diagnosis?
Topics: Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; Disease Progression; Echocardiography; Fluorodeoxyglucose F18; Giant Cells; Granuloma; Heart Block; Heart Failure; Heart Transplantation; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Natriuretic Peptide, Brain; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Troponin I | 2021 |
Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET.
Topics: Adult; Aged; Cardiomyopathies; Fatty Acids; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Iodobenzenes; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sarcoidosis; Tomography, Emission-Computed, Single-Photon | 2021 |
Quantitative FDG PET/CT to Guide Treatment of Cardiac Sarcoidosis: A Crucial Step Forward.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Sarcoidosis | 2021 |
Multiple bone lesions in a patient with fatigue: case report of bone sarcoidosis.
Topics: Fatigue; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2022 |
Identification of Isolated Hepatic Sarcoidosis With 18F-FDG PET/CT and MRI.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Beyond Covid-19 vaccination-associated pitfalls on [
Topics: COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; SARS-CoV-2; Vaccination | 2021 |
FLT PET/CT and FDG PET/CT of Skeletal Muscle Sarcoidosis.
Topics: Aged; Biopsy; Diagnosis, Differential; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
[Multiple lesions on a PET-scan].
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis | 2022 |
Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naïve cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Tachycardia, Ventricular; Tomography, X-Ray Computed | 2022 |
The Importance of Glucose Optimization Prior to FDG-PET Imaging in the Diagnosis of Cardiac Sarcoidosis.
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Pulmonary Artery
Topics: Fluorodeoxyglucose F18; Humans; Hypertension, Pulmonary; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Predictive Value of Tests; Pulmonary Artery; Radiopharmaceuticals; Sarcoidosis | 2022 |
Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2022 |
Incremental Prognostic Value of Global Longitudinal Strain and 18F-Fludeoxyglucose Positron Emission Tomography in Patients With Systemic Sarcoidosis.
Topics: Adult; Cardiomyopathies; Echocardiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Ventricular Function, Left | 2017 |
Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2017 |
Sarcoid Myofasciitis.
Topics: Adrenal Cortex Hormones; Fasciitis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Muscle, Skeletal; Myositis; Positron-Emission Tomography; Quadriceps Muscle; Radiopharmaceuticals; Sarcoidosis; Sarcoidosis, Pulmonary | 2017 |
A rare case of sarcoidosis in accessory spleen.
Topics: Aged; Choristoma; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Diseases; Positron-Emission Tomography; Sarcoidosis; Spleen; Tomography, X-Ray Computed | 2017 |
18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Optical Devices; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Silicon; Tonsillar Neoplasms | 2017 |
Topics: Adult; Atrioventricular Block; Coronary Angiography; Coronary Artery Disease; Female; Finland; Fluorodeoxyglucose F18; Heart; Heart Ventricles; Humans; Inflammation; Male; Middle Aged; Myocardium; Observer Variation; Positron-Emission Tomography; Prevalence; Retrospective Studies; Sarcoidosis; Sex Factors; Tachycardia, Ventricular | 2019 |
Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Severity of Illness Index | 2018 |
Emergence of Integrated Cardiac Magnetic Resonance/Positron Emission Tomography Imaging as the Preferred Imaging Modality in Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Sarcoidosis | 2018 |
Multiorgan Involvement of Chemotherapy-Induced Sarcoidosis Mimicking Progression of Lymphoma on FDG PET/CT.
Topics: Biopsy; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Recurrence; Sarcoidosis | 2017 |
Search for key manifestations to predict inflammation on cardiac PET in suspected cardiac sarcoidosis population.
Topics: Atrioventricular Block; Cardiomyopathies; Female; Finland; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Prevalence; Sarcoidosis | 2019 |
Using and Interpreting
Topics: Fluorodeoxyglucose F18; Humans; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2017 |
FDG PET-CT findings of extra-thoracic sarcoid are associated with cardiac sarcoid: A rationale for using FGD PET-CT for cardiac sarcoid evaluation.
Topics: Aged; Diet, Carbohydrate-Restricted; Diet, High-Fat; Diet, High-Protein; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcoidosis | 2019 |
Joint SNMMI-ASNC Expert Consensus Document on the Role of
Topics: Cardiomyopathies; Consensus; Documentation; Expert Testimony; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Sarcoidosis; Societies, Medical; Treatment Outcome | 2017 |
Paraneoplastic Sarcoidosis in Multiple Myeloma.
Topics: Aged; Biopsy; Bone Diseases; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Mediastinum; Multiple Myeloma; Paraneoplastic Syndromes; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2017 |
Joint SNMMI-ASNC expert consensus document on the role of
Topics: Cardiomyopathies; Consensus; Defibrillators, Implantable; Fluorodeoxyglucose F18; Humans; Pacemaker, Artificial; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis | 2017 |
The logic and challenges of imaging sarcoidosis with whole body FDG PET.
Topics: Fluorodeoxyglucose F18; Humans; Logic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2019 |
Maximizing the Prognostic Value of Cardiac PET in Patients With Suspected Cardiac Sarcoidosis: A Simple Semiquantitative Score May Help.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Sarcoidosis | 2018 |
Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Topics: Adult; Aged; Cardiomyopathies; Coronary Circulation; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Severity of Illness Index; Time Factors | 2018 |
Cardiac sarcoidosis after glucocorticoid therapy evaluated by
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Glucocorticoids; Granuloma; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis | 2018 |
Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients.
Topics: Analysis of Variance; Cardiomyopathies; Cohort Studies; Female; Finland; Fluorodeoxyglucose F18; Follow-Up Studies; Hospitals, University; Humans; Lymph Nodes; Male; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Reference Values; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Severity of Illness Index | 2018 |
Candida oesophagitis incidentally detected by fluorine-18 fluorodeoxyglucose positron emission tomography in a patient with sarcoidosis.
Topics: Candida albicans; Candidiasis; Esophagitis; Female; Fluconazole; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiographic Image Enhancement; Sarcoidosis; Treatment Outcome | 2017 |
A 54-year-old man with new-onset ventricular fibrillation.
Topics: Biopsy; Cardiomyopathies; Cardiopulmonary Resuscitation; Defibrillators; Electric Countershock; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Ventricular Fibrillation | 2017 |
A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American
Topics: Biopsy; Cardiology; Cardiomyopathies; Diagnostic Imaging; Echocardiography; Europe; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Myocardial Perfusion Imaging; Nuclear Medicine; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Reproducibility of Results; Sarcoidosis; Societies, Medical; Tomography, X-Ray Computed; United States | 2018 |
A 52-Year-Old Man With Unheralded Syncope.
Topics: Atrioventricular Block; Bradycardia; Bundle-Branch Block; Cardiomyopathies; Echocardiography; Electrocardiography; Exercise Test; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Syncope; Tomography, Emission-Computed, Single-Photon | 2017 |
Reply: Using and Interpreting
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2017 |
Novel ECG parameters are strongly associated with inflammatory
Topics: Adult; Cardiomyopathies; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sarcoidosis | 2017 |
Serial FDG-PET/CT Imaging in the Management of Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Sarcoidosis; Time Factors | 2018 |
Pembrolizumab-Related Sarcoid-Like Reaction Presenting as Reactivation of Quiescent Scars.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Biomarkers, Tumor; Biopsy; Cicatrix; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Positron-Emission Tomography; Sarcoidosis; Skin | 2018 |
Isolated cardiac sarcoidosis - A rare disease entity?
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Sarcoidosis | 2018 |
Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiomyopathies; Cause of Death; Cohort Studies; Death, Sudden, Cardiac; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Sarcoidosis; Sensitivity and Specificity; Survival Analysis; Young Adult | 2018 |
Cardiac Sarcoidosis Concomitant with Large-vessel Aortitis Detected by
Topics: Aortitis; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Sarcoidosis | 2018 |
Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis.
Topics: Aged; Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2018 |
Establishing an Evidence-Based Method to Diagnose Cardiac Sarcoidosis: The Complementary Use of Cardiac Magnetic Resonance Imaging and FDG-PET.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis | 2018 |
A case of longitudinal care of a patient with cardiac sarcoidosis.
Topics: Adult; Biopsy; Cardiomyopathies; Echocardiography; Electrocardiography; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Male; Multimodal Imaging; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Practice Guidelines as Topic; Radiography, Thoracic; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon | 2018 |
11C-4DST PET/CT Imaging of Cardiac Sarcoidosis: Comparison With 18F-FDG and Cardiac MRI.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Thionucleosides; Thymidine | 2018 |
Cutaneous Manifestation of Sarcoidosis in Lower-Back Tattoo With Increased Uptake of 18F-FDG.
Topics: Adult; Back; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tattooing | 2018 |
Left atrial sarcoidosis as a substrate for peri-mitral atrial flutter: an unusual, underlying atrial disease.
Topics: Atrial Flutter; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2018 |
Prognostic role of serial quantitative evaluation of
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Tachycardia, Ventricular | 2018 |
Spontaneous Reduction in Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxygluose in a Patient with Cardiac Sarcoidosis.
Topics: Aged; Atrioventricular Block; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Myocardium; Positron-Emission Tomography; Sarcoidosis | 2018 |
Usefulness of 18F-FDG-PET/CT imaging in a patient with neurosarcoidosis.
Topics: Adult; Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2018 |
18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes.
Topics: Adult; Aged; Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2020 |
Diagnostic value of cardiac magnetic resonance and fluorodeoxyglucose-positron emission tomography for cardiac sarcoidosis with previous myocardial infarction: A case report.
Topics: Aged; Atrioventricular Block; Fluorodeoxyglucose F18; Heart Failure; Humans; Magnetic Resonance Angiography; Male; Multimodal Imaging; Myocardial Infarction; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2018 |
Importance of extracardiac FDG uptake to diagnose cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron-Emission Tomography; Sarcoidosis | 2020 |
Optimizing cardiac sarcoid imaging with FDG PET: Lessons from studies of physiologic regulation of myocardial fuel substrate utilization.
Topics: Fluorodeoxyglucose F18; Heart; Humans; Myocardium; Positron-Emission Tomography; Sarcoidosis | 2020 |
Stop that glucose getting to heart!
Topics: Animals; Diet, Ketogenic; Fluorodeoxyglucose F18; Glucose; Humans; Mice; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2020 |
Use of
Topics: Adult; Aged; Algorithms; Area Under Curve; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity | 2019 |
The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Odds Ratio; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Risk; Sarcoidosis; Tomography, X-Ray Computed | 2020 |
Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.
Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Sarcoidosis; Young Adult | 2019 |
Assessing severity of cardiac sarcoid: Is SUV the answer?
Topics: Fluorodeoxyglucose F18; Heart; Humans; Myocarditis; Prognosis; Sarcoidosis | 2020 |
FDG PET/CT Course of Pembrolizumab-Associated Multiorgan Sarcoidosis.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Biopsy; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2019 |
Topics: Aged; Biopsy; Cardiomyopathies; Echocardiography; Female; Fluorodeoxyglucose F18; Fluoroscopy; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2020 |
Prognostic Impact of FDG-PET/CT Images in Patients With Suspected Cardiac Sarcoidosis: Optimal Patient Preparation, Not Complex Unconventional Analytics, Is Key to Meaningful Data.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Sarcoidosis | 2019 |
The Authors Reply.
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Sarcoidosis | 2019 |
Cardiac FDG/PET imaging mimicking sarcoidosis.
Topics: Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Thrombosis | 2019 |
Tiger man sign in sarcoid myopathy.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscular Diseases; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2019 |
Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis.
Topics: Cardiomyopathies; Female; Fibrosis; Fluorodeoxyglucose F18; Gadolinium; Heart; Humans; Imaging, Three-Dimensional; Inflammation; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2020 |
Imaging cardiac sarcoidosis with FDG-PET: Take a look at the right side!
Topics: Biopsy; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Positron-Emission Tomography; Sarcoidosis | 2020 |
Diagnostic performance of F
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis | 2020 |
FDG-PET in possible cardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events.
Topics: Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2021 |
Prognostic value of phase analysis on gated single photon emission computed tomography in patients with cardiac sarcoidosis.
Topics: Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume | 2021 |
Regional
Topics: Adult; Aorta; Atherosclerosis; Coronary Vessel Anomalies; Coronary Vessels; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Imaging, Three-Dimensional; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pulmonary Artery; Sarcoidosis; Tomography, X-Ray Computed | 2020 |
Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Drug Therapy, Computer-Assisted; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Time Factors | 2019 |
Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis.
Topics: Aged; Cardiomyopathies; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2019 |
Systemic sarcoidosis presenting as complete heart block in a patient with normal chest radiography.
Topics: Adult; Aftercare; Defibrillators, Implantable; Diagnosis, Differential; Echocardiography; Fluorodeoxyglucose F18; Glucocorticoids; Heart Block; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Prednisone; Rare Diseases; Sarcoidosis; Spleen; Treatment Outcome; Ventricular Dysfunction, Left | 2019 |
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography; Sarcoidosis; Whole Body Imaging | 2019 |
Cardiac sarcoidosis mimicking myocardial infarction: a comprehensive evaluation using computed tomography and positron emission tomography.
Topics: Aged; Biopsy; Disease Progression; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2020 |
Left atrial involvement of cardiac sarcoidosis manifesting as left atrial re-entrant tachycardia.
Topics: Cardiomyopathies; Contrast Media; Diagnosis, Differential; Echocardiography, Transesophageal; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Magnetic Resonance Imaging, Cine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tachycardia, Supraventricular | 2019 |
Prognostic insights of molecular imaging in cardiac sarcoidosis.
Topics: Cardiovascular Diseases; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Prognosis; Sarcoidosis | 2021 |
18FDG PET for Detecting Renal Granulomatous Localization: Illustration of Granulomatosis With Polyangiitis and Sarcoidosis.
Topics: Fluorodeoxyglucose F18; Granulomatosis with Polyangiitis; Humans; Kidney Diseases; Positron-Emission Tomography; Sarcoidosis | 2021 |
Scar Sarcoidosis 10 Years After Videothoracoscopy: Incidental Diagnosis at
Topics: Cicatrix; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2020 |
[Sarcoidosis-lymphoma syndrome showing abnormal FDG uptake in lymph nodes and muscles upon post-chemotherapy PET/CT imaging].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2019 |
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoidosis; Skin Diseases | 2019 |
Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart Transplantation; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity | 2019 |
Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study.
Topics: Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Organometallic Compounds; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Sensitivity and Specificity | 2021 |
Neurosarcoidosis and infliximab therapy monitored by 18FDG PET/CT.
Topics: Anti-Inflammatory Agents; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Infliximab; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2019 |
Preparation is everything: The impact of a structured preparation protocol on cardiac
Topics: Fluorodeoxyglucose F18; Heart; Humans; Positron-Emission Tomography; Sarcoidosis | 2021 |
Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2019 |
Isolated Muscular Sarcoidosis Revealed by Hypercalcemia and 18F-FDG PET/CT.
Topics: Adult; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Hypercalcemia; Muscles; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2019 |
A Case of Sarcoidosis After Lymphoma.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Sarcoidosis | 2019 |
Somatostatin receptor imaging in active cardiac sarcoidosis: Would less be enough?
Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Sensitivity and Specificity | 2021 |
Nivolumab-Associated Pulmonary and Bone Sarcoidosis in a Patient With Melanoma of Unknown Primary.
Topics: Bone Diseases; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphadenopathy; Male; Melanoma; Middle Aged; Neoplasms, Unknown Primary; Nivolumab; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2019 |
Cardiac sarcoid or arrhythmogenic right ventricular cardiomyopathy: a role for positron emission tomography (PET)?
Topics: Arrhythmogenic Right Ventricular Dysplasia; Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis | 2013 |
(18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Prospective Studies; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis.
Topics: Chronic Disease; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Interest of [18F]FDG PET/CT for treatment efficacy assessment in aggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nose Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Predictors of cardiac sarcoidosis using commonly available cardiac studies.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Imaging Techniques; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2013 |
Cardiac FDG-PET to assess sarcoidosis in a cardiac allograft.
Topics: Allografts; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis | 2014 |
Dramatic change in 18F-FDG uptake in a sarcoidosis case showing spontaneous recovery.
Topics: Biological Transport; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Remission, Spontaneous; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Prevalence of vocal cord paralysis in patients with incidentally discovered enlarged lymph nodes along the expected course of the recurrent laryngeal nerve.
Topics: Cohort Studies; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Diseases; Lymphatic Metastasis; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Recurrent Laryngeal Nerve; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed; United States; Vocal Cord Paralysis | 2013 |
Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
Topics: Aged; Atrioventricular Block; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventricular Septum | 2013 |
Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease.
Topics: Acute Disease; Aged; Cardiac Imaging Techniques; Female; Fluorodeoxyglucose F18; Gadolinium; Heart Diseases; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2013 |
Clinical utility of a magnetic resonance-conditional pacemaker in a patient with cardiac sarcoidosis.
Topics: Atrioventricular Block; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Magnetic Resonance Imaging; Middle Aged; Pacemaker, Artificial; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
Topics: Adult; Aged; Area Under Curve; Atrioventricular Block; Cardiomyopathies; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Perfusion Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Registries; ROC Curve; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular; Tomography, X-Ray Computed; Ventricular Function, Left | 2013 |
Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis.
Topics: Adult; Aged; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Infliximab; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Receptors, Interleukin-2; Recurrence; Retrospective Studies; Sarcoidosis; Time Factors | 2014 |
Muscular sarcoidosis detected by F-18 FDG PET/CT in a hypercalcemic patient.
Topics: Female; Fluorodeoxyglucose F18; Humans; Hypercalcemia; Kidney Calculi; Lymph Nodes; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Steroids; Tomography, X-Ray Computed | 2013 |
Detection of sarcoidosis associated fasciitis by uptake on a FDG PET scan: a novel finding.
Topics: Animals; Fasciitis; Fluorodeoxyglucose F18; Humans; Myositis; Positron-Emission Tomography; Sarcoidosis | 2013 |
Sarcoidosis mimicking metastatic bone disease in head and neck cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Bone Neoplasms; Diagnosis, Differential; Ethmoid Sinus; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Topics: Cardiomyopathies; Coronary Circulation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Perfusion Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rubidium Radioisotopes; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular | 2014 |
Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
(18)F-FDG-PET CT findings in a patient with early-phase cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Atrioventricular Block; Electrocardiography; Fluorodeoxyglucose F18; Heart Diseases; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Myocardium; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Rubidium Radioisotopes; Sarcoidosis; Treatment Outcome; Ventricular Function, Left | 2014 |
Isolated right ventricular cardiac sarcoidosis demonstrated by ¹⁸FDG positron emission tomography.
Topics: Adult; Cardiomyopathy, Dilated; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Ventricular Dysfunction, Right | 2014 |
Necessity for rule out coronary artery disease with the positive findings of 18F-FDG-PET in case of systemic sarcoidosis.
Topics: Aged; Coronary Artery Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2014 |
Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
Topics: Cardiomyopathies; Diet; Fasting; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Time Factors; Whole Body Imaging | 2014 |
Lung cancer with sarcoid reaction in the lymph nodes following chemoradiotherapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Cisplatin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Irinotecan; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiation Dosage; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Mediastinal sarcoid-like reaction after colon adenocarcinoma resection.
Topics: Adenocarcinoma; Aged; Biopsy; Colectomy; Colonic Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Mediastinal Diseases; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Time Factors; Tomography, X-Ray Computed | 2015 |
Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Atrioventricular Block; Biopsy; Cardiomyopathies; Defibrillators, Implantable; Disease-Free Survival; Electric Countershock; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Immunosuppressive Agents; Male; Middle Aged; Ontario; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prospective Studies; Radiopharmaceuticals; Recurrence; Risk Factors; Sarcoidosis; Tachycardia, Ventricular; Time Factors; Tomography, X-Ray Computed; Young Adult | 2014 |
Whole-body magnetic resonance imaging in extrathoracic sarcoidosis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Receptors, Interleukin-2; Sarcoidosis; Severity of Illness Index; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Ocular sarcoidosis: does (18)F-FDG PET/CT have any role?
Topics: Adult; Eye; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Netherlands; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Diffuse renal (18)F-FDG uptake of a patient with fever of unknown origin revealed sarcoidosis.
Topics: Biopsy; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Kidney; Middle Aged; Positron-Emission Tomography; Sarcoidosis | 2014 |
Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.
Topics: Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis.
Topics: Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Image Interpretation, Computer-Assisted; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Chronic sialadenitis with marked lymphadenopathy mimicking lymphoma on FDG PET/CT.
Topics: Diagnostic Errors; Exocrine Glands; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sialadenitis; Tomography, X-Ray Computed | 2014 |
FDG PET for gauging of sarcoid disease activity.
Topics: Fluorodeoxyglucose F18; Granuloma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Function Tests; Sarcoidosis; Sarcoidosis, Pulmonary; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Imaging cardiac sarcoidosis by cardiac positron emission tomography (PET): a local experience using a high-fat, low-to-no carbohydrate protocol.
Topics: Adult; Cardiac Imaging Techniques; Cardiomyopathies; Clinical Protocols; Diet, Carbohydrate-Restricted; Diet, High-Fat; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.
Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Mediastinal sarcoidosis mimicking lymph malignancy recurrence after anti-neoplastic therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gastrectomy; Granuloma; Humans; Hysterectomy; Lymphatic Irradiation; Lymphatic Metastasis; Mastectomy, Segmental; Mediastinal Diseases; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
The great mimicker: an extensive bone sarcoidosis.
Topics: Bone and Bones; Bone Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2015 |
[False positive result of 18F-FDG PET in patient with lung cancer due to sarcoid-like reaction in regional lymph nodes].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Positron-Emission Tomography; Sarcoidosis | 2014 |
Sarcoidosis mimicking metastatic breast cancer on FDG PET/CT.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Seminoma; Testicular Neoplasms | 2015 |
[Evaluation of bronchial mucosa involvement in sarcoidosis patients using ¹⁸F-FDG PET-CT].
Topics: Bronchi; Bronchoalveolar Lavage Fluid; CD4-CD8 Ratio; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Respiratory Mucosa; Retrospective Studies; Sarcoidosis | 2014 |
Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed | 2015 |
[Active cardiac sarcoidosis: Diagnosis and adjustment of therapy with FDG PET/CT].
Topics: Adult; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2015 |
Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency.
Topics: Biomarkers; Diabetic Nephropathies; Female; Fluorodeoxyglucose F18; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Heart Failure; Humans; Male; Middle Aged; Nephrotic Syndrome; Pilot Projects; Positron-Emission Tomography; Receptors, Interleukin-2; Regression Analysis; Renal Insufficiency; Retrospective Studies; Sarcoidosis | 2015 |
Pleomorphism during Ventricular Tachycardia: A Distinguishing Feature between Cardiac Sarcoidosis and Idiopathic VT.
Topics: Adult; Cardiomyopathies; Contrast Media; Diagnosis, Differential; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tachycardia, Ventricular; Tomography, X-Ray Computed | 2015 |
False-positive (13)N-ammonia/(18)FDG PET for evaluation of cardiac sarcoidosis in a patient on peritoneal dialysis.
Topics: Ammonia; Cardiomyopathies; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Peritoneal Dialysis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2015 |
Role of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and treatment of sarcoidosis in an HIV-2-infected patient.
Topics: Adult; Female; Fluorodeoxyglucose F18; HIV Infections; HIV-2; Humans; Positron-Emission Tomography; Sarcoidosis | 2015 |
Presence of macronodules in thoracic sarcoidosis: prevalence and computed tomographic findings.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Male; Middle Aged; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Thoracic Diseases; Tomography, X-Ray Computed | 2015 |
Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis.
Topics: Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tuberculosis, Cardiovascular; Young Adult | 2015 |
Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
Topics: Aged; Cardiomyopathies; Dimensional Measurement Accuracy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
Topics: Adrenal Cortex Hormones; Aged; Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Heart Block; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2015 |
Evaluation of Mediastinal Lymph Nodes in Sarcoidosis, Sarcoid Reaction, and Malignant Lymph Nodes Using CT and FDG-PET/CT.
Topics: Adult; Aged; Diagnosis, Differential; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Respiratory Function Tests; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed | 2015 |
Cardiac sarcoidosis with visually normal wall motion: role of cardiac MRI, FDG PET, and strain echocardiography.
Topics: Cardiomyopathies; Echocardiography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2015 |
The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarco
Topics: Adult; Aged; Cardiomyopathies; Diet, Carbohydrate-Restricted; Fasting; Fatty Acids, Nonesterified; Female; Fluorodeoxyglucose F18; Heparin; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2016 |
The Evaluation of Cardiac Sarcoidosis with 18F-FDG PET.
Topics: Aged; Fluorodeoxyglucose F18; Heart; Humans; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Sarcoidosis | 2016 |
Undiagnosed cardiac sarcoidosis presenting as complete heart block and ventricular arrhythmia.
Topics: Cardiomyopathies; Defibrillators, Implantable; Fluorodeoxyglucose F18; Heart Block; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Tachycardia, Ventricular | 2015 |
Cardiac positron emission tomography imaging with quantification of fluorodeoxyglucose for the detection of cardiac sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Myocardium; Sarcoidosis | 2015 |
Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Conduction System; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2016 |
Visual Vignette.
Topics: Adult; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Hypogonadism; Hypothalamic Diseases; Magnetic Resonance Imaging; Male; Pituitary Diseases; Sarcoidosis | 2015 |
F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Topics: Cardiomyopathies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Nodes; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis | 2015 |
Diagnostic efficacy of ultrasound-guided core-needle biopsy of peripheral lymph nodes in sarcoidosis.
Topics: Adult; Aged; Biopsy, Large-Core Needle; Databases, Factual; Female; Fluorodeoxyglucose F18; France; Granuloma; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Palpation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Young Adult | 2015 |
Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.
Topics: Adult; Aged; Biopsy; Cardiomyopathies; Contrast Media; Early Diagnosis; Fatty Acids; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Iodobenzenes; Japan; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2015 |
Diagnostic Performance of Diffusion-Weighted Imaging for Multiple Hilar and Mediastinal Lymph Nodes with FDG Accumulation.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Multimodal Imaging; Pneumoconiosis; Positron-Emission Tomography; Prospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Cardiac Sarcoidosis Detected by (18)F-Fluorodeoxyglucose Positron Emission Tomography.
Topics: Cardiomyopathy, Dilated; Fluorodeoxyglucose F18; Heart Diseases; Humans; Lymphadenopathy; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2016 |
Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis.
Topics: Adult; Biological Transport; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Receptors, Interleukin-2; Sarcoidosis; Spleen | 2016 |
MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis.
Topics: Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2015 |
Two cases of cardiac sarcoidosis diagnosed based on biopsy results of the gluteus muscle with focal uptake of 18F-fluorodeoxyglucose.
Topics: Biopsy; Buttocks; Cardiomyopathies; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2016 |
Left ventricular asynchrony in early isolated cardiac sarcoidosis.
Topics: Adult; Cardiomyopathies; Coronary Angiography; Early Diagnosis; Fluorodeoxyglucose F18; Gadolinium; Glucocorticoids; Humans; Magnetic Resonance Imaging, Cine; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2016 |
Simultaneous cardiac imaging to detect inflammation and scar tissue with (18)F-fluorodeoxyglucose PET/MRI in cardiac sarcoidosis.
Topics: Cardiomyopathies; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2016 |
Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Diet; Diet, Carbohydrate-Restricted; Endocarditis; Female; Fluorodeoxyglucose F18; Glucose; Heart; Heparin; Humans; Inflammation; Male; Middle Aged; Myocardium; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Young Adult | 2016 |
Right ventricular mass: a rare presentation of cardiac sarcoidosis.
Topics: Adult; Cardiomyopathies; Echocardiography; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Magnetic Resonance Angiography; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2016 |
Managing FDG PET-positive sarcoidosis: "a riddle wrapped in a mystery inside an enigma".
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis | 2016 |
Managing FDG PET-positive sarcoidosis: "a riddle wrapped in a mystery inside an enigma".
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis | 2016 |
Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
Topics: alpha-Methyltyrosine; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2016 |
Diagnosis, therapeutic response assessment, and detection of disease recurrence in cardiac sarcoidosis: Integral role of cardiac PET.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis | 2016 |
Lack of Increased FDG Uptake in the Lacrimal and Salivary Glands in Patients With Sarcoidosis and Potential Underlying Mechanism.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus; Male; Middle Aged; Multimodal Imaging; Parotid Gland; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Glands; Sarcoidosis; Tomography, X-Ray Computed | 2016 |
FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
FDG PET/CT in bone sarcoidosis.
Topics: Adult; Aged; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Prospective Studies; Radiopharmaceuticals; Sarcoidosis | 2016 |
F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Sodium Fluoride | 2017 |
Malfunctioned cardiac resynchronization therapy attributed to acute exacerbation of cardiac sarcoidosis.
Topics: Adult; Cardiac Resynchronization Therapy; Cardiomyopathies; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Heart Failure; Humans; Male; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2016 |
Sarcoid Pericarditis and Large Vessel Vasculitis Detected on FDG PET/CT.
Topics: Aged; Aorta; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Pericarditis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Vasculitis | 2016 |
Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
Topics: Adult; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocardial Infarction; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2017 |
Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?
Topics: Antirheumatic Agents; Case-Control Studies; Fluorodeoxyglucose F18; Humans; Infliximab; Leukocyte Count; Monocytes; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, IgG; Sarcoidosis | 2016 |
Osseous Sarcoidosis Mimicking Metastatic Cancer on Positron Emission Tomography.
Topics: Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma; Low Back Pain; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sodium Fluoride; Tomography, X-Ray Computed | 2016 |
18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT.
Topics: Central Nervous System Diseases; Dura Mater; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis | 2016 |
Cardiac manifestations of sarcoidosis: diagnosis and management.
Topics: Adolescent; Adult; Aged; Biomarkers; Biopsy; Cardiomyopathies; Death, Sudden, Cardiac; Defibrillators, Implantable; Early Diagnosis; Echocardiography; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Young Adult | 2017 |
Cardiac sarcoidosis: An important niche for PET, but a journey just begun.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2017 |
Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2018 |
Ventricular fibrillation via torsade des pointes of cardiac sarcoidosis with preserved left ventricular ejection fraction.
Topics: Aged; Biopsy; Cardiomyopathies; Contrast Media; Defibrillators, Implantable; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Torsades de Pointes; Ventricular Fibrillation | 2016 |
The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis.
Topics: Cardiomyopathies; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Subtraction Technique; Treatment Outcome | 2017 |
Multimodality imaging in the diagnosis and management of cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis | 2017 |
Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Cardiomyopathies; Cohort Studies; Drug Resistance; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2017 |
Cardiac involvement in rheumatoid arthritis mimicking sarcoidosis on FDG PET-CT and MR imaging.
Topics: Adult; Arthritis, Rheumatoid; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Gadolinium; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Multimodal Imaging; Myocardium; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2018 |
Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Diet, Carbohydrate-Restricted; Diet, High-Fat; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2017 |
An atypical sarcoidosis involvement in FDG PET/CT: A case report.
Topics: Fluorodeoxyglucose F18; Humans; Laryngeal Diseases; Larynx; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2016 |
Neurosarcoidosis on FET and FDG PET/CT.
Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine | 2017 |
Reticuloendothelial system involvement in untreated sarcoidosis patients as assessed by 18F-FDG PET scanning.
Topics: Biomarkers; Fluorodeoxyglucose F18; Humans; Mononuclear Phagocyte System; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Interleukin-2; Sarcoidosis; Whole Body Imaging | 2016 |
Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.
Topics: Ammonia; Blood Flow Velocity; Cardiomyopathies; Coronary Circulation; Female; Fluorodeoxyglucose F18; Humans; Hyperemia; Immunosuppressive Agents; Male; Middle Aged; Myocardial Perfusion Imaging; Myocarditis; Nitrogen Radioisotopes; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Time Factors; Treatment Outcome; Vasodilation | 2017 |
Quantitative Assessment of Myocardial Blood Flow in Cardiac Sarcoidosis: A Potential Next Step in the Further Integration of FDG-PET in Imaging Management?
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2017 |
Monitoring the Therapy of Extensive Osseous Sarcoidosis With FDG PET/CT.
Topics: Biopsy; Bone Diseases; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sarcoidosis; Treatment Outcome | 2017 |
The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2008 |
Pharyngolaryngeal sarcoidosis: report of 12 cases.
Topics: Adult; Aged; Aged, 80 and over; Bromhexine; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Diseases; Male; Middle Aged; Pharyngeal Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2008 |
Does 18F-fluorodeoxyglucose PET/CT have a role in the management of pulmonary and extra pulmonary sarcoidosis?
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2008 |
Donor cell-derived sarcoidosis after allogeneic BMT.
Topics: Bone Marrow Transplantation; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Follicular; Middle Aged; Prognosis; Radiopharmaceuticals; Remission Induction; Sarcoidosis; Transplantation, Homologous; Treatment Outcome | 2009 |
Laryngeal sarcoidosis detected by FDG positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Laryngeal Diseases; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2008 |
Fluorine-18 fluorodeoxyglucose with positron emission tomography revealed bone marrow involvement in sarcoidosis patients with anaemia.
Topics: Adult; Anemia; Bone Marrow Diseases; Case-Control Studies; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Middle Aged; Positron-Emission Tomography; Sarcoidosis | 2010 |
18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Receptors, Interleukin-2; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Solubility | 2009 |
The many faces of sarcoidosis: asymptomatic muscle mass mimicking giant-cell tumor.
Topics: Adult; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Magnetic Resonance Imaging; Male; Muscular Diseases; Positron-Emission Tomography; Sarcoidosis | 2009 |
Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Diseases; Male; Mediastinal Diseases; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed | 2009 |
[Usefulness of fluorodeoxyglucose-positron emission tomography in a case of pleural sarcoidosis].
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2009 |
[Intestinal sarcoidosis--an unusual manifestation of a granulomatous systemic disease].
Topics: Child; Contrast Media; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gadolinium DTPA; Humans; Ileal Diseases; Ileum; Image Processing, Computer-Assisted; Inflammation Mediators; Jejunal Diseases; Jejunum; Lymph Nodes; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Spiral Computed | 2010 |
18F-FDG PET successfully detects spinal cord sarcoidosis.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Cord Diseases | 2009 |
Clinical images: Muscle sarcoidosis demonstrated on positron emission tomography.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Muscle Weakness; Muscle, Skeletal; Positron-Emission Tomography; Sarcoidosis | 2009 |
Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis.
Topics: Anti-Inflammatory Agents; Azathioprine; Diagnosis, Differential; Encephalitis; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Myelitis, Transverse; Positron-Emission Tomography; Predictive Value of Tests; Sarcoidosis; Sarcoidosis, Pulmonary; Spinal Cord; Steroids; Temporal Lobe; Treatment Outcome | 2009 |
[Isolated sarcoidosis of the spleen and liver as incidental ultrasound finding].
Topics: Abdominal Pain; Adult; Biopsy; Contrast Media; Diagnosis, Differential; Fatigue; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver; Liver Diseases; Phospholipids; Positron-Emission Tomography; Sarcoidosis; Spleen; Splenic Diseases; Sulfur Hexafluoride; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDG-PET.
Topics: Adrenal Cortex Hormones; Documentation; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis | 2009 |
Imaging in sinonasal sarcoidosis: CT, MRI, 67Gallium scintigraphy and 18F-FDG PET/CT features.
Topics: Adult; Aged; Blood Glucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nose Deformities, Acquired; Nose Diseases; Paranasal Sinus Diseases; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Recurrence; Sarcoidosis; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2010 |
Interesting image. F-18 fluorodeoxyglocose positron emission tomography/computed tomography in the diagnosis of chronic myopathic sarcoidosis.
Topics: Aged; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Myositis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2010 |
[Usefulness of FDG-PET for monitoring the effects of therapy in sarcoidosis patients].
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2009 |
F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nervous System Diseases; Positron-Emission Tomography; Radiography, Thoracic; Sarcoidosis; Thymidine; Tomography, X-Ray Computed | 2010 |
The diagnostic challenge of mediastinal sarcoidosis accompanying esophageal cancer.
Topics: Adenocarcinoma; Aged; Decision Making; Diagnosis, Differential; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Mediastinal Diseases; Middle Aged; Neoplasms, Squamous Cell; Palliative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2010 |
18F-fluoro-deoxyglucose PET for monitoring treatment in sarcoidosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Magnetic Resonance Imaging; Pituitary Gland; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Follow-up of muscular sarcoidosis using fluorodeoxyglucose positron emission tomography.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Infliximab; Male; Muscle Weakness; Muscular Diseases; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |
Clinical problem-solving. The beat goes on.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; Echocardiography; Electrocardiography; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Middle Aged; Myocardium; Prednisone; Sarcoidosis; Tachycardia, Ventricular; Ventricular Dysfunction, Right | 2010 |
Cardiac sarcoidosis mimicking non-ST-elevation myocardial infarction.
Topics: Adult; Cardiomyopathies; Diagnosis, Differential; Electrophysiologic Techniques, Cardiac; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Myocardial Infarction; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2012 |
Images in cardiovascular medicine: Imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: an autopsy case.
Topics: Fatal Outcome; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Male; Middle Aged; Papillary Muscles; Positron-Emission Tomography; Sarcoidosis | 2010 |
FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Spinal Cord Compression; Spinal Cord Diseases; Spondylosis | 2011 |
Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Cardiomyopathies; Cardiomyopathy, Dilated; Fasting; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Time Factors; Treatment Outcome; Ultrasonography | 2010 |
18F-FDG PET/CT for the diagnosis of sarcoidosis in a patient with bilateral inflammatory involvement of the parotid and lacrimal glands (panda sign) and bilateral hilar and mediastinal lymphadenopathy (lambda sign).
Topics: Adult; Fluorodeoxyglucose F18; Humans; Inflammation; Lacrimal Apparatus; Male; Mediastinum; Parotid Gland; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2011 |
Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET.
Topics: Adult; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Sarcoidosis, Pulmonary; Sensitivity and Specificity | 2011 |
FDG PET coregistered to MRI for diagnosis and monitoring of therapeutic response in aggressive phenotype of sarcoidosis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Phenotype; Positron-Emission Tomography; Sarcoidosis; Treatment Outcome | 2011 |
Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
Topics: Aged; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon | 2011 |
An unusual presentation of sarcoidosis with tetraplegia and severe osteolytic bone lesions.
Topics: Bone and Bones; Fluorodeoxyglucose F18; Granuloma; Humans; Immunosuppressive Agents; Male; Middle Aged; Osteolysis; Positron-Emission Tomography; Quadriplegia; Radionuclide Imaging; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed; Uveitis; Whole Body Imaging; Young Adult | 2012 |
F-18 FDG PET/CT findings in a case of spinal cord sarcoidosis.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Sarcoidosis; Spinal Cord Diseases; Tomography, X-Ray Computed | 2011 |
Diagnosing isolated cardiac sarcoidosis.
Topics: Adult; Biopsy; Cardiomyopathies; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed | 2011 |
18F-FDG PET/CT detects systemic involvement in sarcoidosis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2011 |
Be aware of disseminated sarcoidosis with diffuse subcutaneous nodules on F-18 FDG PET.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis; Skin | 2011 |
Early detection of cardiac sarcoid lesions with (18)F-fluoro-2-deoxyglucose positron emission tomography.
Topics: Aged; Cardiomyopathies; Early Diagnosis; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Sarcoidosis | 2011 |
Clinical images: Bone sarcoidosis mimicking multiple metastases.
Topics: Adult; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Low Back Pain; Magnetic Resonance Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoidosis; Technetium Tc 99m Pentetate; Tomography, X-Ray Computed | 2011 |
Cutaneous sarcoidosis evaluated by FDG PET.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Skin Diseases; Tomography, X-Ray Computed | 2011 |
FDG PET/CT in evaluation of pyrexia of unknown origin.
Topics: Adult; Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Still's Disease, Adult-Onset; Thyroiditis, Autoimmune; Tomography, X-Ray Computed | 2011 |
Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis.
Topics: Cardiomyopathies; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Severity of Illness Index | 2011 |
F-18 FDG PET/CT in the diagnosis of a rare case of neurosarcoidosis in a patient with diabetes insipidus.
Topics: Adult; Central Nervous System Diseases; Diabetes Insipidus; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2011 |
Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Neopterin; Netherlands; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Predictive Value of Tests; Quality of Life; Radiopharmaceuticals; Receptors, Interleukin-2; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
PET scan: findings in a patient with severe cutaneous and systemic sarcoidosis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoidosis; Skin | 2011 |
Diagnosis of cardiac sarcoidosis through mismatched defects seen on N-13 NH3/F-18 FDG cardiac PET.
Topics: Ammonia; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Positron-Emission Tomography; Radiography; Sarcoidosis | 2011 |
Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal, Humanized; Biopsy, Needle; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Injections, Subcutaneous; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Prednisolone; Prospective Studies; Respiratory Function Tests; Sarcoidosis; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients.
Topics: Adult; Aged; Bone Marrow Diseases; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Netherlands; Osteitis; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Young Adult | 2012 |
Sarcoidosis manifesting as cardiac sarcoidosis and massive splenomegaly.
Topics: Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Splenomegaly | 2012 |
Refractory multisystem sarcoidosis responding to infliximab therapy.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Infliximab; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prednisolone; Remission Induction; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer.
Topics: Biopsy; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Multimodality evaluation of cardiac sarcoidosis.
Topics: Adult; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Subtraction Technique; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2012 |
Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and 18F-FDG PET-CT.
Topics: Adult; Contrast Media; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
FDG PET findings leading to diagnosis of neurosarcoidosis.
Topics: Adult; Biopsy; Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Polyradiculopathy; Positron-Emission Tomography; Sarcoidosis | 2013 |
Pulmonary sarcoidosis mimicking multiple pulmonary metastases.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
[Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2012 |
The value of [18F]-fluorodeoxyglucose-positron emission tomography/CT scanning in the diagnosis of neurosarcoidosis.
Topics: Adult; Central Nervous System; Central Nervous System Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Knee; Male; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Sarcoidlike reaction of neoplasia causing hypermetabolic thoracic adenopathy in setting of extrathoracic malignancy: report of two cases and a review of the differential diagnostic considerations.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Sacrum; Sarcoidosis; Thorax; Tomography, X-Ray Computed | 2012 |
Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis.
Topics: Aged; Biomarkers; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Middle Aged; Muramidase; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Stroke Volume; Troponin T; Ventricular Function, Left | 2012 |
Hepatic sarcoidosis with an increased serum level of immunoglobulin G4.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunoglobulin G; Liver Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.
Topics: Aged; Diet, Carbohydrate-Restricted; Diet, High-Fat; Dietary Carbohydrates; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Ambulatory; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
18F-FDG PET/CT imaging of extensive systemic sarcoidosis with epididymal involvement.
Topics: Adult; Epididymis; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Dual time point positron emission tomography/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis.
Topics: Aged; Diagnosis, Differential; Endemic Diseases; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Histoplasmosis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, X-Ray Computed; United States; United States Department of Veterans Affairs | 2013 |
Earlobe sarcoidosis.
Topics: Antibodies, Monoclonal; Ear Auricle; Ear Diseases; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Severity of Illness Index; Treatment Outcome | 2012 |
Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heparin; Humans; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
Topics: Cicatrix; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nervous System Diseases; Radiopharmaceuticals; Sarcoidosis; Spine; Thorax; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
PET imaging using a triple-head gamma camera.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Oligodendroglioma; Phantoms, Imaging; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy.
Topics: Bone Diseases; Bone Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis; Sarcoidosis, Pulmonary; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
FDG-positron emission tomographic imaging in carcinoma of the breast: interference by massive sarcoidosis.
Topics: Adult; Breast Neoplasms; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sarcoidosis; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
Topics: Adult; Aged; Ammonia; Carbon Isotopes; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2003 |
F-18 FDG PET: mottled splenomegaly with remission of symptoms after splenectomy in sarcoidosis.
Topics: Chills; Fatigue; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Remission Induction; Sarcoidosis; Splenectomy; Splenomegaly; Tomography, Emission-Computed; Treatment Outcome | 2004 |
FDG positron emission tomography of bone involvement in sarcoidosis.
Topics: Adult; Bone Diseases; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed | 2004 |
Failure of follow-up gallium single-photon emission computed tomography and fluorine-18-fluorodeoxyglucose positron emission tomography to predict the deterioration of a patient with cardiac sarcoidosis.
Topics: Cardiomyopathies; Echocardiography; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Middle Aged; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon; Treatment Failure; Ventricular Function, Left | 2004 |
Diagnostic Value of PET in Cardiac Sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Citrates; Female; Fluorodeoxyglucose F18; Gallium; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Thallium; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
Topics: Adult; Aged; Blood Glucose; Fasting; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2004 |
Benign lesions in cancer patients: Case 1. Sarcoidosis after chemoradiation for head and neck cancer.
Topics: Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Sarcoidosis | 2005 |
Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy.
Topics: Adult; Brain Diseases; Citrates; False Negative Reactions; Fluorodeoxyglucose F18; Gallium; Humans; Lung Diseases; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2005 |
Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Technetium Tc 99m Sestamibi | 2005 |
[Fluorodeoxyglucose-positron emission tomographic findings in a patient with pacing failure].
Topics: Aged; Cardiomyopathies; Equipment Failure; Female; Fluorodeoxyglucose F18; Heart Block; Humans; Pacemaker, Artificial; Sarcoidosis; Tomography, Emission-Computed | 2005 |
False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2005 |
Bilateral Gasser's ganglion sarcoidosis: diagnosis, treatment and unsolved questions.
Topics: Adrenal Cortex Hormones; Adult; Cranial Nerve Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Functional Laterality; Humans; Hypesthesia; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Trigeminal Ganglion | 2005 |
[Cardiac sarcoidosis detected by FDG-PET].
Topics: Aged; Cardiac Pacing, Artificial; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2005 |
Pseudotumoral renal sarcoid: MRI, PET, and MDCT appearance with pathologic correlation.
Topics: Adult; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kidney Diseases; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2005 |
Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 1. Mediastinal sarcoidosis in a melanoma patient treated with interferon.
Topics: Antiviral Agents; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Interferon alpha-2; Interferon-alpha; Lymphatic Metastasis; Mediastinal Neoplasms; Melanoma; Middle Aged; Polyethylene Glycols; Positron-Emission Tomography; Recombinant Proteins; Sarcoidosis; Sentinel Lymph Node Biopsy | 2005 |
Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2005 |
Guess the diagnosis. Lymphoma or sarcoidosis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2005 |
False-positive uptake of FDG in hepatic sarcoidosis.
Topics: Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Diseases; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Whole Body Imaging | 2006 |
Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
Topics: Adult; Bronchial Neoplasms; Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Radiopharmaceuticals; Sarcoidosis; Somatostatin; Tomography, Emission-Computed | 2006 |
Images in cardiology. Cardiac sarcoidosis in a 60 year old woman.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2006 |
Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy.
Topics: Adult; Cardiomyopathies; Chest Pain; Female; Fluorodeoxyglucose F18; Humans; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Steroids; Tissue Distribution; Treatment Outcome | 2006 |
Combined C-11 methionine and F-18 FDG PET imaging in a case of neurosarcoidosis.
Topics: Biopsy; Carbon Radioisotopes; Cerebellar Ataxia; Cerebellar Diseases; Cerebellar Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mediastinum; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2006 |
Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed | 2006 |
F-18 FDG PET imaging of disseminated sarcoidosis.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Sarcoidosis | 2007 |
FDG PET/CT demonstrated rapid progression of mediastinal lymphadenopathy in sarcoidosis.
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Mediastinal Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2007 |
Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sarcoidosis | 2007 |
[Malignant struma ovarii: false positive PET image for suspected metastasis due to sarcoidosis].
Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Thyroid Gland | 2007 |
Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT.
Topics: Axilla; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Middle Aged; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed | 2007 |
Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bronchoscopy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methyltyrosines; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Tomography, Emission-Computed, Single-Photon | 2007 |
[Sarcoidosis demonstrated by fluorodeoxyglucose positron emission tomography in a case of granulomatous myopathy].
Topics: Fluorodeoxyglucose F18; Granuloma; Humans; Male; Middle Aged; Myositis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Whole Body Imaging | 2007 |
18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart Block; Humans; Male; Middle Aged; Pacemaker, Artificial; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Syncope | 2007 |
Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
Topics: Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Middle Aged; Pituitary Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Experiences and benefits of positron emitted tomography-computed tomography (PET-CT) combined with video-assisted thoracoscopic surgery (VATS) in the diagnosis of Stage 1 sarcoidosis.
Topics: Adult; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2007 |
Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Sarcoidosis; Spleen; Tomography, X-Ray Computed; Vincristine | 2007 |
Diffuse spine involvement in sarcoidosis with sternal lytic lesions: two case reports.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Osteolysis; Osteosclerosis; Pain; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Diseases; Sternum; Tomography, X-Ray Computed | 2007 |
Uncommon extent involvement of sarcoidosis in 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteitis; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Sarcoidosis; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
A failed case to diagnose cardiac sarcoidosis presenting advanced atrioventricular block.
Topics: Anti-Inflammatory Agents; Atrioventricular Block; Cardiomyopathies; Diagnostic Errors; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Organ Failure; Prednisolone; Sarcoidosis; Uveitis | 2008 |
Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Tomography, Emission-Computed; Whole Body Imaging | 2007 |
Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Subtraction Technique | 2008 |
Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging.
Topics: Adult; Aged; Blood Glucose; Citrates; Female; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Humans; Lung; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis; Whole-Body Irradiation | 2008 |
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Sarcoidosis; Vinblastine | 2008 |
Imaging of sarcoidosis: self-assessment module.
Topics: Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2008 |
FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
Topics: Aged; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2008 |
Sarcoidosis.
Topics: Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2008 |
Central skeletal sarcoidosis mimicking metastatic disease.
Topics: Biopsy; Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Early detection of cardiac sarcoidosis: comparison of 18F-FDG PET with 11C-choline PET.
Topics: Adult; Aged; Carbon Radioisotopes; Cardiomyopathies; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2007 |
Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
Topics: Adult; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Diseases; Lymphoma; Male; Middle Aged; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Is there a role for FDG PET imaging in the management of patients with sarcoidosis?
Topics: Citrates; Citric Acid; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymph Nodes; Lymphoma; Sarcoidosis; Sarcoidosis, Pulmonary; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Cancer or inflammation? A Holy Grail for nuclear medicine.
Topics: Citrates; Citric Acid; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Inflammation; Lymphoma; Neoplasms; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
High fluorine-18 labeled deoxyglucose uptake in sarcoidosis.
Topics: Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Mediastinal Diseases; Mediastinoscopy; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1996 |
Seminoma and sarcoidosis: a cause for false positive mediastinal uptake in PET?
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Sarcoidosis; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed | 1998 |
[Usefulness of fluorine-18 fluoro-2-deoxyglucose positron emission tomography for diagnosis and therapy assessment of cardiac sarcoidosis].
Topics: Animals; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Middle Aged; Sarcoidosis; Tomography, Emission-Computed; Treatment Outcome | 2000 |
FDG PET in the clinical evaluation of sarcoidosis with bone lesions.
Topics: Adult; Bone Diseases; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Radiography; Sarcoidosis; Tomography, Emission-Computed | 2000 |
Elevated uptake of F-18 FDG in PET scans in nonmalignant disease.
Topics: Abdomen; Female; Fluorodeoxyglucose F18; Foreign Bodies; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed | 2000 |
Cervical lymph node sarcoidosis as a pitfall in F-18 FDG positron emission tomography.
Topics: Aged; Diagnosis, Differential; Ear, External; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Neck; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2001 |
PET and PLAP in suspected testicular cancer relapse: beware sarcoidosis.
Topics: Adult; Alkaline Phosphatase; Diagnosis, Differential; Fluorodeoxyglucose F18; GPI-Linked Proteins; Humans; Immunohistochemistry; Isoenzymes; Lung Neoplasms; Lymphatic Diseases; Male; Mediastinum; Radiopharmaceuticals; Sarcoidosis; Testicular Neoplasms; Tomography, Emission-Computed | 2001 |
Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis.
Topics: Adult; Chronic Disease; Electrocardiography; Fluorodeoxyglucose F18; Granuloma; Heart; Heart Block; Humans; Lymph Nodes; Male; Nitrogen Radioisotopes; Predictive Value of Tests; Prednisolone; Recovery of Function; Sarcoidosis; Thallium Radioisotopes; Tomography, Emission-Computed | 2002 |